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Abstract
Hard tissues, such as bone and teeth, are natural composites of collagen nanofibers that
are reinforced by inorganic calcium phosphate nanocrystallites, in the form of
nanocomposites. The interlocking between these components in hard tissues explains
their unique characteristics. Bone is mainly classified into two major types; compact
and cancellous depending on the extent of porosity. Fractures in compact bone can be
treated using bone fixation implants, such as rods, screws and plates, or can be totally
replaced by bone implants if complete substitution is required. Cancellous bone, on
the other hand, is highly porous and its substitution with synthetic biomaterials is a
challenge. The current study investigates the use of a 3D printing technology to
fabricate 3D porous scaffolds that can be used as substitutes of fractured cancellous
bone. Three types of polymers have been investigated because of their classification
as bioactive (poly(ethylene terephthalate); PET), biodegradable (poly(lactic acid);
PLA) and bioinert (Acrylonitrile-butadiene-styrene terpolymer); ABS). All polymers
were 3D printed into highly porous scaffolds that were further chemicallyfunctionalized to enhance their surface properties, hence improve their potential
application as bone implants. Both as-printed and chemically functionalized porous
scaffolds were characterized for their structure and morphology. Moreover,
chemically-treated PET and PLA scaffolds were investigated for their preliminary in
vitro performance in a simulated body fluid (SBF) medium, while chemically
conditioned ABS scaffolds were used as platform to grow a biodegradable metalorganic framework (HKUST-1) onto their surfaces. Preliminary results of the current
study showed the potential of the chemically functionalized porous scaffolds to be
used as implants for the partial and total replacement of defective porous bone.

Keywords: Bone implant, 3D printing, porous scaffolds, biomimetic, metal-organic
framework.
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)Title and Abstract (in Arabic

تصنيع هياكل مسامية ثالثية األبعاد معالجة كيميائيا ً للتطبيقات الطبيّة الحيويّة
الملخص

تعتبر األنسجة الصلبة ،مثل العظام واألسنان ،مركبات طبيعية من ألياف الكوالجين
النانوية المعززة بواسطة بلورات فوسفات الكالسيوم النانوية غير العضوية .يفسر التشابك بين هذه
المكونات في األنسجة الصلبة خصائصها الفريدة .تصنف العظام بشكل رئيسي إلى نوعين؛ مدمج
وإسفنجي حسب درجة المسامية.حيث يمكن عالج الكسور في العظام المضغوطة باستخدام بدائل
العظام ،مثل القضبان والمسامير واأللواح ،أو يمكن استبدالها بالكامل بزرع العظام إذا كان
االستبدال الكامل مطلوبًا .من ناحية أخرى ،فإن العظام اإلسفنجية شديد المسامية واستبدالها بمواد
حيوية اصطناعية يمثل تحديًا .تبحث الدراسة الحالية في استخدام تقنية الطباعة ثالثية األبعاد
لتصنيع بدائل مسامية ثالثية األبعاد يمكن استخدامها كبديل للعظام اإلسفنجية المكسورة .تمت
دراسة ثالثة أنواع من البوليمرات حسب تصنيفها على أنها نشطة بيولوجيًا (بولي(إيثيلين
تيريفثاالت)؛ ،)PETقابلة للتحلل (بولي(حمض الالكتيك)؛ ،)PLAوخاملة بيولوجيًا
)(أكريلونيتريل بيوتادين ستايرين تريبوليمر)؛  .)ABSحيث تمت طباعة جميع البوليمرات ثالثية
األبعاد في صورة أجسام مسامية للغاية تم معالجتها كيميائيًا لتعزيز خصائص سطوحها ،وبالتالي
تحسين تطبيقها المحتمل كبدائل عظمية .تم توصيف كل من السقاالت المسامية المطبوعة
والمعالجة كيميائيا ً من حيث هيكلها وتشكلها .عالوة على ذلك  ،تم فحص أجسام  PETو PLA
المعالجة كيميائيا ً من أجل أدائها األولي في المختبر في وسط مماثل للسائل الحيوى بالجسم ()SBF
بينما تم استخدام سقاالت ABSالمعالجة كيميائيا ً كمنصة لتنمية إطار عضوي معدني قابل للتحلل
( )HKUST-1على أسطحها .أظهرت النتائج األولية للدراسة الحالية إمكانية استخدام األجسام
المسامية المعالجة كيميائيا ً لالستبدال الجزئي أوالكلي للعظام المسامية المعيبة.
مفاهيم البحث الرئيسية :زرع العظام ،الطباعة ثالثية األبعاد ،سقاالت مسامية ،محاكاة بيولوجية،
إطار عضوي معدني.
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Chapter 1: Introduction

1.1 Bone Structure
Bone is a hard tissue that constitutes the human skeleton, which is defined as
the hard framework of human body around which the entire body is built. Human
skeleton is composed of three main components, namely, bones and teeth, associated
cartilages and joints. Bone is a tough and rigid form of connective tissue. It is the
weight-bearing organ of whole body and is, therefore, responsible for the mechanical
properties of the human skeleton (Umadevi & Geethalakshmi, 2011). Bone is a
dynamic and highly vascularized tissue that continues to remodel throughout the
lifetime of an individual. In addition to its main strengthening as part of the skeleton
system, bone is intimately involved in homeostasis through its storage of calcium
(Ca2+) and phosphate (PO43-) ions and by regulating the concentration of key
electrolytes in the blood (Feng, 2009).
1.1.1 Types of Bone
Bone can be either compact or cancellous (spongy), as shown in Figure 1
(Themes, 2016). Compact bone, also known as cortical bone, makes up the major
portion of the skeletal mass. However, cortical bone has a low surface area because of
its high density. The basic functional unit of mature compact bone is the osteon or
Haversian system. In an osteon, the osteocytes are arranged in concentric layers around
a central canal, or Haversian canal. This canal contains one or more blood vessels that
carry blood to and from the osteon. Central canals generally run parallel to the surface
of the bone. The lamellae of each osteon form a series of nested cylinders around the
central canal. In cancellous or spongy bone, lamellae are not arranged in osteons.
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Cancellous bone is trabecular (has an open, meshwork or honeycomb-like structure).
It has a relatively high surface area, but forms a smaller portion of the skeleton, as
shown in Figure 2 (Ghosh, 2008; Sadat-Shojai et al., 2013 ;Zioupos et al., 2008).

Figure 1: Section of compact and cancellous bone (Flat bone).
Section (A) showing part of two types of bone, (B) compact and (C) cancellous.

Figure 2: The hierarchical structure of typical bone at various length scales.
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The bone tissue is a mineralized connective tissue. Bone-forming cells called
osteoblasts deposit a matrix of collagen, but they also release calcium, magnesium,
and phosphate ions, which chemically combine and harden within the matrix into the
mineral hydroxyapatite. The combination of hard mineral and flexible collagen makes
bone harder than cartilage without being brittle (Berner et al., 2004; Ghosh, 2008).
1.1.2 Bone Composition
Bone, as a calcified tissue, is composed of 60% of inorganic components, 30%
of organic components and proteins and 10% of water & living cells (Themes, 2016).
Inorganic component includes 85% hydroxyapatite (HAp), (crystallized calcium
phosphate salt), 10% calcium carbonate and other minerals that contains ions such as
fluoride, sodium, potassium, magnesium. Bone mineral HAp has essentially a
stoichiometric Ca/P molar ratio of 1.67 and a nominal structure of Ca10(PO4)6(OH)2
(Qi et al., 2012; Zhou & Lee, 2011). However, a number of ionic substitutions may
take place including Na+, K+, Mg2+, Sr2+ for Ca2+ ions, and CO32- for PO43-, and F- for
OH- ions. Some of these substitutions play significant roles in the structure and
mechanical properties of the bone mineral. The crystals are aligned along the axis of
the collagen fibrils and reinforce the collagen matrix to provide a very strong and tough
composite, as shown in Figure 2 (Ghosh, 2008).
The organic component of bone is protein in nature and contains 95% type I
collagen and 5% of proteoglycans and none-collagenous proteins (Kruger et al., 2013).
Collagen is an organic polymer, which is also known as a mechanically tough protein,
hence it makes up the major fraction of the structure of skeletal connective tissues.
There are 13 types of collagen in the body (Ghosh, 2008).
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1.2 Bone Fractures
One of the most common bone illnesses is a bone fracture. Other illnesses are
for example, osteoporosis and bone cancer (osteosarcoma). The mineral content of
bone increases with age, reaching a maximum value, represented by “peak bone
density” in humans of different genders at different ages. With the process of natural
maturing, the overall bone mineral content decreases, leading to diseases such as
osteoporosis, but not necessarily with decrease in the proportion of mineral in any
bone. Osteomalacia, on the other hand, is defined as a loss of bone mineral and an
increase in osteoid. Conversely, osteoporosis is an increase in both bone mineral and
bone matrix, beyond that necessary for normal function (Ghosh, 2008; Kalkwarf et al.,
2007).
Bone fracture, on the other hand, is defined as a medical condition in which
there is a breakage in the continuity of the bone. Fractures can happen in a variety of
ways, but there are three common causes: trauma fractures (accidents), osteoporosis
and stress or overuse. In general, bone fractures can be categorized as simple or multifragmentary fractures. Simple fractures describe a single fracture line throughout a
bone with the broken parts still in their normal anatomical position. This leads to a
minimal damage to the surrounding tissues. Multi-fragmentary, on the other hand,
refers to a fracture in which there are two or more bone fragments present (Doblaré et
al., 2004; Umadevi & Geethalakshmi, 2011).
The symptoms and overall signs of a fracture vary according to the age and
health of the patient, as well as the severity of the injury. However, a common set of
symptoms occur, such as pain, swelling, bruising, discolored skin around the affected
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area, and angulation (Brazier, Y. 2017).
Long bone fractures can be classified to open, closed and comminuted
fractures, as shown in Figure 3a. An open fracture, also referred to as a compound
fracture, is a type of fracture that is known by an open wound on the skin that overlays
a broken bone and carry a higher risk of infection. A closed fracture, which is also
known as a simple fracture, is a type of fracture where the broken bone does not
protrude out of the skin (Difference, 2019; Pape & Webb, 2008). A complicated
fracture, on the other hand, is a fracture of the bone that is combined with a lesion of
an organ, artery, nerve bundle, or joint (Umadevi & Geethalakshmi, 2011).

Figure 3: Long bone fractures as open or closed.

Long bone Fractures can also be further classified to the following different
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categories, as shown in Figure 3b:
1. Transverse fracture: which is the break is in a horizontal fracture line across
the bone.
2. Oblique fracture: which is complete fractures that usually occur at a plane
oblique to the axis of a long bone.
3. Spiral/ twisting fracture: which is caused by a twisting force and caused a
spiral-shaped fracture line.
4. Comminuted fracture: which is a fracture in which bone is broken into 3 or
more fragments & all fragments are present at the fracture site.
5. Segmental fracture: where the same bone should be fractured in two places.
6. Greenstick fracture: which is an incomplete fracture in which the bone is
bent and cracks, and occurs most often in children.
7. Linear fracture: which runs parallel to the long axis of a bone. Also called
fissured fracture (Brazier, 2017).
1.3 Bone Healing
Bone healing is a highly complex regenerative process that reiterates aspects
of embryological skeletal development, thus restoring injured skeletal tissue. This
remarkable regenerative capacity may be related to the common molecular
mechanisms of fetal skeletal development and bone repair (Peters et al., 2010).
Bone has the capability to retain the potential for regeneration in adult life, as
it possesses considerable capabilities of repair. Unlike other tissues that heal by the
formation of a connective tissue scar of poor quality, bone is regenerated and the prefracture properties are frequently restored. The expression of this unique characteristic
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applies either to the periodical re-modelling of the human skeleton or to the healing
torrent of bone fractures (Giannoudis et al., 2007).
Fracture healing restores the tissue to its original physical, and mostly
mechanical properties. However, it is affected by a range of systemic and local factors.
Healing occurs in three distinct but overlapping stages: early inflammatory stage,
repair stage and late remodeling stage (Einhorn & Gerstenfeld, 2015; Kalfas, 2001).

Figure 4: Femur fracture repair.

The major metabolic phases (shown in blue bars) of fracture healing overlap
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with the biological stages (shown in brown bars). The primary metabolic phases (both
anabolic and catabolic) of fracture healing are presented in the framework of three
major biological stages (inflammatory, endochondral bone formation and coupled
remodeling) that incorporate these phases (Echeverri et al., 2015; Kini & Nandeesh,
2012).
1.4 Fixation of Bone Fracture
Bone graft is the second most common transplantation tissue, with blood being
the most common. Furthermore, the treatment of post-traumatic skeletal
complications, such as delayed unions, nonunions, malunions, are usually challenging.
Bone-grafting is usually required to stimulate bone-healing. In addition, spinal fusions,
filling defects following removal of bone tumors and several congenital diseases may
require bone grafting (Bauer & Muschler, 2000; Giannoudis et al., 2005). Types of
bone substitutions will be outlined in the following sections.
1.4.1 Natural Bone Substitutions
These include autografts and allografts. Although these are the known standard
treatment procedures, a number of disadvantages are encountered with their usage.
Since bone grafts are avascular and depend on the size of the defect, the viability of
the host tissues can limit their application. Furthermore, the new bone bulk formation
can be challenging due to unpredictable bone resorption. It was observed in large
defects that the grafts are resorbed by the body before osteogenesis is completed. Two
additional problems are known in this regard: harvesting autografts is an expensive
process. Second, the donor tissue is scarce and there can be significant donor site
morbidity associated with pain, infection, and hematoma. Moreover, the process of
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allografting introduces the risk of infection and/or disease, which may result in
loosening or complete loss of the bone. Vascularized grafts require a major
microsurgical operative procedure, which requires a complicated infrastructure (Burg
et al., 2000; Miron et al., 2013).
1.4.1.1 Bone Autografts
Bone autografts are bone that is transplanted from one area of the skeleton to
another to aid in healing, strengthening or improving bone function. Bone or bone-like
materials used in bone grafts may come from a regular human donor or from a manmade source. In many cases they are used to fill in an empty space that may have been
created in or between the bones of the spine by disease, injury, deformity or during a
surgical procedure such as spinal fusion (Campana et al., 2014; Etemad, 2012). An
osseous graft harvested from an anatomic site and transplanted to another site within
the same individuals is called autologous bone grafting (Wang & Yeung, 2017).
Filling of bone defects is a significant inquiry in every day clinical work.
Autograft or autogenous bone is still the most effective bone graft substitution
material, where it fulfils all required physical, chemical and biological properties, in
spite of its inherent limitations, such as availability, and post-operative pain. The most
common alternatives to the autograft material are (human) allografts or (animal, e.g.
bovine) xenografts. Allografts have the disadvantages of limited supply and potential
contamination (e.g. HIV, Hepatitis). In case of xenografts, there are the problems of
critical immune response as well as its infectivity.
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Autogenous bone is characterized by being:
a) Osteogenic: where cells within a donor graft can induce the formation of
new bone at the implantation site.
b) Osteoinductive: where new bone is formed by the active employment of
host mesenchymal stem cells from the surrounding tissues, which then
undergo a process of differentiation into bone-forming osteoblasts.
c) Osteoconductive: which indicates vascularization and new bone formation
into the transplant) and highly biocompatible. This process is facilitated by
the presence of growth factors within the autogenous bone material (mainly
bone morphogenetic proteins (Tadic, 2004).

Cancellous autografts are widely known as the most commonly used form of
autologous bone grafting. Few osteoblasts and osteocytes, as well as abundant
mesenchymal stem cells (MSCs) survive as a result of ischemia during transplantation,
which helps maintain osteogenic potential, hence the ability to generate new bone from
the graft. However, a number of drawbacks of the autograft have been extensively
observed, and are related to the harvesting process, induced pain, donor site
complication, increased blood loss, increased operative time, potential for donor site
infection and limited stock of material available (Wang & Yeung, 2017).
Furthermore, autografts, as most of the cellular (osteogenic) implants, may fail
to survive transplantation. Other limitations include elderly or paediatric patients and
patients with malignant disease. In addition autograft harvesting is associated with a
8.5—20% of complications, such as haematoma formation, blood loss, nerve injury,
hernia formation, infection, arterial injury, ureteral injury, fracture, pelvic instability,
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cosmetic defects, tumor transplantation, and sometimes chronic pain at the donor site
(Giannoudis et al., 2005).
1.4.1.2 Allograft
Allografts are bony tissues that are harvested from one individual and
transplanted to a genetically different individual. Considering the problems
aforementioned of autologous bone grafts, bone allograft is considered the most
reasonable alternative to autografts and has been used effectively in clinical practice,
especially for patients with poor healing potential, established nonunion, and extensive
post-fractures comminution. An allograft may be machined and customized, and is
therefore available in a variety of forms, including cortical, cancellous and highly
processed bone derivatives (Delloye et al., 2007; Wang & Yeung, 2017).
Allograft is the most frequently chosen bone substitute and is regarded as the
surgeon’s second option. The current increasing availability of allograft tissue has
made it possible to customize it in various forms, such as dowels, strips, and chips.
Allograft bone has more limitations in the essential bone graft characteristics described
earlier and yields flexible clinical results. However, allografts carry the risk of
transferring viral diseases. Processing of allograft tissues lowers this risk. However, it
can significantly deteriorate the biologic and mechanical properties initially present in
the bone tissue (Giannoudis et al., 2005).
1.4.2 Naturally-Derived Grafts
1.4.2.1 DBM (Demineralized Bone Matrix)
Demineralized bone matrix can be produced through decalcification of cortical
bone. Then, is processed in order to reduce the potential for infection and
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immunogenic host response. The material produced, the DBM, preserves the
trabecular collagenous structure of the original tissue and can serve as a biologic
osteoconductive scaffold. However, a possible loss of structural strength may occur.
Demineralized bone still contain a number of bone growth factors, thus become more
bio-available after the removal of the mineral phase. Therefore, DBM can be more
osteoinductive than standard mineralized allograft. DBM is widely used as a ‘‘bone
graft extender’’ rather than as a bone graft substitute (Giannoudis et al., 2005; Gruskin
et al., 2012).
DBM is considered a highly processed allograft derivative with at least 40% of
the mineral content of the bone matrix removed by mild acid, hence maintaining
collagens, noncollagenous proteins and growth factors. Due to the lower structural
integrity and mechanical properties of DBM, their application is mainly for filling
bone defects. The osteoconductivity of the DBM is referred by providing a framework
for cell populating and for generating new bone after the demineralization process.
The integration of the DBM is similar to that of the autogenous graft, with growth
factors activating an endochondral ossification cascade and resulting in new bone
formation at the site of implantation (M. Zhang et al., 1997; Wang & Yeung, 2017).
1.4.2.2 Extracellular Bone matrix
This type of bone matrix is very rich in collagen, which is a known component
that contributes to mineral deposition, vascular ingrowth, and growth factor binding,
providing a suitable environment to the process of bone regeneration. Nevertheless,
collagen may cause potential immunogenicity and results in minimal structural
support. Studies indicate the recent application of collagen as a delivery system for
other osteoconductive, osteoinductive, or osteogenic factors, showing in promising
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clinical results. Collagen functions poorly as a graft material but once is coupled with
bone morphogenetic proteins (BMPs), osteoprogenitor precursors, or hydroxyapatite
(HAp), hence enhances significantly graft incorporation. Collagen is also commonly
used in the form of a composite with other bone substitutes, hence can be used as
effective autograft extenders (Cheng et al., 2003; Giannoudis et al., 2005).
1.4.2.3 Coralline Hydroxyapatite
Coralline hydroxyapatite is a natural material derived from sea coral. Certain
sea coral species produce a porous structure made by calcium phosphate (coralline)
using a hydrothermal process, hence made similar to human cancellous bone. This is
suitable as osteoconductive substitute for bone graft. The average pore size of a
coralline HAp is within the range for bone ingrowth. Despite its high compressive
strength, coralline HAp is brittle and has low tensile strength. It has been used in the
management of fractures of the tibial plateau as a filler material and the results have
been comparable to those obtained with autogenous bone graft. Recently, corallineHAp has been used as a carrier for some growth factors and BMPs (Holmes, 1979;
Giannoudis et al., 2005).
1.4.3 Synthetic Derived Grafts
Considerable advances have been made with synthetic materials to be used as
alternatives over the past decade that make them comparable to autograft. Ideally
synthetic bone graft substitutes should be biocompatible, show minimal fibrotic
interaction, undergo remodeling and support formation of new bone. From the
mechanical properties point of view, synthetic bone substitutes should have similar
strength to that of the cortical/cancellous bone to be replaced (Giannoudis et al., 2005).
Examples of current recognized synthetic grafts will be discussed.
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1.4.3.1 Calcium Phosphate & Calcium Sulfates Ceramics
Synthetic calcium phosphate ceramics with their known excellent
biocompatibility are common alternatives to autogeneous bone, xenograft or allograft
materials. They have gained acceptance for several dental or medical applications
which include, e.g., fillers for periodontal defects, alveolar ridge augmentation,
maxillofacial reconstruction, ear implants, spine fusion, and coatings for metallic bone
implants. Synthetic calcium phosphates (such as -tricalcium phosphate; -TCP, and
hydroxyapatite; HAp) are commonly used as plates, blocks, cements, pastes, fine
powders or coarse granules (Pietrzak & Ronk, 2000; Tadic, 2004).
Calcium sulfate, on the other hand, is a kind of osteoconductive and
biodegradable ceramics composed of CaSO4 and has been applied in filling void
defects since 1892. It is prepared by hydrating -hemihydrate crystal structure and can
be made in different forms, such as hard pellets or injectable viscous fluids that harden
in vivo. Although it lacks a macroporous structure, calcium sulfate still has a rapid
resorption rate and weak internal mechanical properties, which implies that it can only
be used to fill small bone defects with rigid internal fixation. The ingrowth of vascular
and new bone takes place in conjunction with the resorption of the graft have reported
that calcium sulfate was unable to achieve an optimal rate of fusion in spinal
arthrodesis, mainly because of faster degradation in early phase of bone regeneration
than the rate of actual bone deposition. However, easy preparation and relative low
cost has made calcium sulfate resurgent when combined with other synthetic bone
substitutes and/or growth factors. One of the promising approaches is to load gypsum
with antibiotics. More recently, gypsum was used to replace PMMA as a cement
spacer, so as to make this technique a single step procedure (Wang & Yeung, 2017).
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1.4.3.2 Bioactive Glass and Glass Ionomer
Glass ionomer cements were first used in dental applications. Ionomeric
cement consists of calcium aluminum fluorosilicate glass powder mixed with polycarboxylic acid to produce a porous cement paste upon solidification. The paste hardens
in 5 min after which it is water insoluble. After 24 h it has a compressive strength and
modulus of elasticity comparable to cortical bone, and is highly biocompatible and
osteointegrates, as compared with bioactive glasses. Moreover, glass ionomer has
porous structure that supports osteoconduction, hence bone ingrowth. It is nonresorbable and therefore is not replaced by bone (Davidson, 2006; Giannoudis et al.,
2005).
1.4.3.3 Scaffold-Based Grafts
One of the most common challenges in bone tissue regeneration is to assist the
restoration of large bone defects that cannot be restorated by the host itself. Due to the
fact that autografts and allografts show various disadvantages including a second
surgery in addition to the high risk of disease transmission, porous scaffolds made of
synthetic biomaterials have been considered more reasonable (Chen et al., 2002; C.
Yang et al., 2018).
The term scaffold is used for three-dimensional (3D) biomaterial structure that
provides a suitable environment for cells to regenerate tissues and organs. The aim is
to produce scaffolds that are able to provide signals to the cells to regenerate and
simulate natural behavior. The presence of high porosity with a high degree of
interconnectivity allow cell attachment to facilitate the regeneration of tissues, growth,
proliferation, and differentiation of cells, diffusion of waste and degradation products
of scaffolds. The pore size within a scaffold must be large enough to allow migration
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of cells, but small enough to allow the binding of cells to the scaffold. It should be
mentioned that materials used for the fabrication of 3D scaffolds must be
biocompatible, easily sterilizable without compromising its chemical integrity, and
have good mechanical properties, as well as encapsulation and chemical
biofunctionalization (Chocholata et al., 2019).
1.5 Tissue Engineering (using Scaffolds Grafts)
Tissue engineering applies methods from materials structure, engineering and
life sciences to create artificial structures for regeneration of new tissue. One common
approach is to isolate specific cells through a small biopsy from a patient to grow them
on a three-dimensional (3D) scaffold under controlled set of culture conditions.
Subsequently, the 3D construct is delivered to the desired site in the patient’s body to
induce new tissue formation into the scaffold that could be degraded over time. An
alternative approach is to implant scaffolds for tissue ingrowth directly in the body
with the objective to stimulate and to direct tissue formation in situ. The advantage of
this approach is to reduce the number of operations needed, resulting in a shorter
recovery time for the patient (Drury & Mooney, 2003; Rezwan et al., 2006).
There are multiple clinical reasons to develop bone tissue-engineering
modalities, including the need for better materials that can be used in the reconstruction
of large orthopaedic defects and the need for hard tissue implants that are mechanically
more acceptable compared with their biological environment. Bone tissue engineering
may potentially provide alternative solutions that provide better mechanical properties
than those currently used. This may decrease the vascular effect of the implant to the
bone and cause lower stress shielding, hence decreasing the incidence of implantrelated osteopenia and the possibility of subsequent re-fracture. The mechanical
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properties of a bone tissue-engineered construct could be modulated to avoid such
circumstances. A related application is the use of a tissue-engineered implant (Burg et
al., 2000).
Scaffolds for tissue engineering should mimic in part the structure and
biological function of the extracellular matrix (ECM). The scaffolds should provide
mechanical support, deliver bone induction molecules or cells to the repair site and
provide approaches to control the structure and function of newly formed tissue. A
number of techniques have been developed to fabricate 3D porous architectures to fill
this role, such as by particle leaching, phase separation and self-assembly. However,
many of these scaffolds do not adequately mimic the structure of the natural ECM in
terms of 3D architecture, which may be one of the reasons for outcomes towards the
process of generating functional tissues(Ikada, 2006; C. Li et al., 2006).
1.5.1 Pre-requisite Properties of Scaffolds
Scaffolds used for the regeneration of defective hard tissue should satisfy a
number of pre-requisites to be accepted as model replacements of hard tissues. These
pre-requisites will be outlined in the following sections.
1.5.1.1 Biocompatibility
This is one of the most important pre-requisites, where scaffolds should be well
integrated in the tissues of the host without eliciting an immune response (Salgado et
al., 2004). Biocompatibility of a scaffold is described as its ability to support normal
cellular activity including molecular signaling systems without any local or systematic
toxic effects to the host tissues. An ideal bone scaffold must be osteoconductive where
the scaffold allows bone cells to adhere, proliferate, and form extracellular matrix on
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its surface and pores. The scaffold should also be able to induce new bone formation,
which is known as osteoconduction that normally takes place through biomolecular
signaling and recruiting progenitor cells. Furthermore, an ideal scaffold needs to form
blood vessels in or around the implant within few weeks of implantation to actively
support nutrient, oxygen, and transport of various types of waste (Bose et al., 2012;
Rocha et al., 2002).
1.5.1.2 Porosity and Pore Size
3D scaffolds used for hard tissue regeneration must possess highly
interconnected porosity with large surface to area volume ratios that will allow cell ingrowth and a highly accurate cell distribution throughout the porous structure, and will
facilitate the neovascularization of the 3D implant from the surrounding tissue.
Furthermore, the scaffolds should also exhibit suitable microporosity, in order to allow
capillary in-growth. Porosity and interconnectivity are also important for an accurate
diffusion of nutrients and for the removal of metabolic waste resulting from the activity
of the cells that had grown into the scaffold. This is of particular importance regarding
bone tissue engineering because, bone metabolic characteristics, high rates of mass
transfer are both expected to occur, even under in vitro culture circumstances.
However, the degree of porosity always influences other properties of the scaffolds
such as its mechanical stability, so, its value, should always be balanced with the
mechanical needs of the particular tissue that is going to be replaced (Karageorgiou &
Kaplan, 2005; Salgado et al., 2004).
Pore size is also a very important parameter because, if the pores employed are
too small, pore occlusion by the cells will take place. This will prevent cellular
penetration, extracellular matrix production, and neovascularization of the inner areas
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of the scaffold. It is well accepted that for bone tissue engineering purposes, pore size
should be within the 200–900 m range. However, Holly et al. reported a different
concept, where bone reconstruction will only be achieved by having a 3D temporary
matrix with a large macroporous interconnected structure with pore size ranging from
1.2–2.0 mm. This later approach has evident advantages due to its high surface to
volume ratios that will facilitate in-growth of cells, tissues and blood vessels.
However, this compromises the mechanical properties. Therefore its use in areas
where high mechanical properties are needed, should be avoided (Salgado et al., 2004).
Interconnectivity of porosity of a scaffold is highly required for a successful
diffusion of essential nutrients and oxygen for cell survivability. However, pore sizes
in the range of 200–350 m are found to be optimum for bone tissue in-growth.
Furthermore, recent studies have indicated that multi-scale porous scaffolds involving
both micro and macro porosities can perform better than only macro porous scaffolds.
Unfortunately, porosity reduces mechanical properties such as compressive strength,
and increases the complexity for the manufacturing of reproducible scaffolds.
Researchers have explored porous scaffolds using polymers, ceramics, composites and
metals. Strength of dense bioceramic materials matches close to the cortical bone, and
different polymers to that of cancellous bone, however ceramic–polymer composite
scaffolds are typically weaker than bone. Porous metallic scaffolds meet the
mechanical requirements of bone, but fail to provide the necessary implant-tissue
integration and propose a major concern related to metal ion leaching (Bose et al.,
2012).
1.5.1.3 Surface Properties
Surface chemical and topographical properties, can control and affect cellular
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adhesion and proliferation. Chemical properties are related to the ability of cells to
adhere to the material as well as with the protein interactions. Topographical properties
are of particular interest, as it is related to osteoconduction, which is defined as the
process by which osteogenic cells migrate to the surface of the scaffold trough a fibrin
clot, which is established right after the material implantation. This migration of
osteogenic cells through the clot will cause retraction of the temporary fibrin matrix.
Hence, it is of the utmost importance that the fibrin matrix is well secured to the
scaffold or, otherwise, when osteogenic cells start to migrate the fibrin will detach
from the scaffolds due to wound contraction. It has been previously shown that a rough
surface will be able to imprison the fibrin matrix, better than a smooth surface, and
hence facilitate the migration of osteogenic cells to the surface of the materials
(Salgado et al., 2004).
1.5.1.4 Osteoinductivity
Osteoinduction is the process by which osteoprogenitor and stem cells are
recruited to a bone healing site, and stimulated to undergo the osteogenic
differentiation pathway. However, when the portion of bone to be regenerated is large,
natural osteoinduction combined with a biodegradable scaffold may not be sufficient.
Because of this the scaffold should be osteoinductive by itself (Albrektsson &
Johansson, 2001; Salgado et al., 2004).
1.5.1.5 Bioresorbability
Bioresorbability is an additional crucial factor for scaffolds in bone tissue
regeneration. An ideal scaffold should not only have similar mechanical properties to
that of the host tissue, but also be able to degrade with time in vivo, preferably at a
controlled resorption rate and eventually creating space for the new bone tissue to
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grow. The degradation behavior of the scaffolds should vary based on applications.
Naturally, design and manufacturing of multi-scale porous scaffolds having ideal
composition including targeted biomolecules, mechanical properties and related
bioresorbability are some of the key challenges today towards their successful
implementation in the tissue engineering of hard tissues (Bose et al., 2012; Rocha et
al., 2002).
1.5.1.6 Mechanical Properties and Biodegradability
Scaffolds should have sufficient mechanical strength to withstand the
hydrostatic pressures and to maintain the spaces required for cell in-growth and matrix
production in vitro. The mechanical properties of the implanted construct should
ideally match those of living bone, so that an early mobilization of the injured site can
be made possible. Furthermore, the scaffolds degradation rate must be tuned
appropriately with the growth rate of the new tissues, in such a way that by the time
the injury site is totally regenerated the scaffold is totally degraded (Reilly & Burstein,
1974; Salgado et al., 2004).
The mechanical properties of an ideal bone scaffold should match host bone
properties and proper load transfer is also important. Mechanical properties of bone
vary widely from cancellous to cortical bone. The large variation in mechanical
properties and geometry makes it difficult to design an ‘ideal bone scaffold’ (Bose et
al., 2012; Woodard et al., 2007).
1.5.2 Materials Used in Scaffolds Grafts
1.5.2.1 Bioceramics
Ceramic materials with higher porosity and lower density provide greater
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surface area for vascularization, and bony ingrowth. The osteoconductive scaffold
provides an appropriate environment for bone cells and bone morphogenetic proteins
(BMPs). Ceramics are synthetic scaffolds made from calcium phosphate that have
been used in dentistry and in orthopaedics since the 1980s. Tri-calcium phosphate
(TCP) ceramic has a chemical stoichiometry similar to amorphous bone precursors,
whereas hydroxyapatite has a stoichiometry similar to bone mineral. Ceramics do not
exist naturally, but they have been shown to induce a biologic response similar to that
of bone. Both TCP-ceramic and HAp are highly biocompatible. They differ, however,
in the biologic response created at the host site: porous TCP-ceramic is removed from
the implant site as bone grows into the scaffold; HAp is more permanent. The surface
layers of TCP-ceramic, enhance bonding with adjacent host bone. This stimulates
osteoclastic resorption and osteoblastic new bone formation within the resorbed
implant. Hydroxyapatite is brittle and undergoes a slow resorption; implants of this
material can become a focus of mechanical stress (Giannoudis et al., 2005; Hing,
2005).
Being a major constituent of bone, calcium phosphates (CaPs) have been
extensively studied as scaffold material for bone tissue engineering. Among different
CaPs, the majority of research has been focused on hydroxyapatite (HAp), tricalcium phosphate (-TCP) or mixture of HAp and -TCP, known as biphasic
calcium phosphate (BCP). These materials have long been studied to fabricate porous
scaffolds for bone tissue engineering. A combination of macro-porosity (250–350 µm)
and micro-porosity (2–8 µm) results in lamellar and woven bone formation in HAp
scaffolds, a property absent in scaffolds without microporosity. Microwave sintered
3D printed -TCP scaffolds with >60% porosity not only facilitated osteoblast activity
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but also aided in the formation of new bone within the pores. Recent results on CaPs
indicate dopant addition in scaffolds can control dissolution rates, densification
behavior, mechanical strength, and biocompatibility. SiO2 (0.5%) and ZnO (0.25%)
doping in -TCP scaffolds can result in a 2.5-fold increase in compressive strength
and up to 92% increase in cell viability by day 11 (Bose et al., 2012). Ceramics have
been widely used in the biomedical engineering and bone substitution/regeneration
field (Salgado et al., 2004; Woodard et al., 2007).
1.5.2.2 Metals and alloys
Metals are considered the oldest materials used for implants. The first recorded
use of metal implants was in old Egyptian times. The first metals used were aluminum,
lead, gold and silver. Nowadays, titanium and its alloys are the most frequently used
metallic biomaterials for dental and orthopedic implants, as a result of their
biocompatibility, non-toxicity and corrosion resistance. Commercially pure titanium
has excellent biocompatibility but relatively poor strength. On the other hand, titanium
alloys have superior strength, but contain ingredients that can be toxic or allergenic.
Metal alloys are applied as joint replacements and fracture-fixation implants, because
of their good biocompatibility, corrosion resistance and esteemed mechanical
properties. Metals are not biodegradable, so there is usually a requirement to remove
metallic implants, especially in the case of children (Chocholata et al., 2019; Kitabata
et al., 2014). Unlike CaP or polymeric scaffolds, biomolecules cannot be integrated
into metallic scaffolds and they are not biodegradable. Moreover, there are concerns
related to metal ion release. Surface modification techniques are often employed to
improve bioactivity of titanium (Ti) scaffolds. Recent developments in bioactive
metals report an orthopedic biodegradable material substitute which can be used
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especially for load-bearing applications. The early stages of in vivo biocompatibility
of magnesium (Mg) scaffolds have recently been established (Bose et al., 2012; Lee et
al., 2009).
1.5.2.3 Polymers
Natural biodegradable polymers are those obtained from natural sources, either
from animal or vegetable source. Natural polymer include collagen, fibrinogen,
chitosan, starch, hyaluronic acid (HA), and poly(hydroxybutyrate). The main
advantages of these materials are their low immunogenic potential, the potential
bioactive behavior and the capability of interacting with the host’s tissue, and chemical
versatility. Synthetic biodegradable polymers that are most widely used are: poly(hydroxy acids), poly(-caprolactone), poly(propylene fumarates), poly(carbonates),
poly(phosphazenes), and poly(anhydrides) (Place et al., 2009; Salgado et al., 2004).
The process of biodegradability, as well as mechanical properties, can be
modified by cross-linking or by combination with inorganic compounds, e.g., HAp.
Collagen-HAp scaffolds have been produced with optimal pore structure for bone
regeneration, where 99% interconnectivity and excellent cell infiltration have been
achieved. Scaffold derived from mouse-bone marrow from mesenchymal stem cells
was implanted into a mouse calvarial defect. After three weeks, the defect was
annealed and after several weeks, degradation of collagen-HAp the scaffold was
proven successful (Chocholata et al., 2019; Woo et al., 2007).
Polymers can be both bioactive and biodegradable. Commonly used natural
polymers for bone tissue engineering are collagen, fibrin, alginate, silk, hyaluronic
acid, and chitosan. Flexibility in processing and ability to tailor the chemistry of
polymers are added advantages. Degradation of synthetic polymers such as poly(lactic
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acid) (PLA), poly(glycolic acid) (PGA), and polycaprolactone (PCL) produces
monomers which are readily removed by the natural physiological pathway. Some
polymers such as poly(propylene fumarate) (PPF) show high compressive strength that
is comparable to cortical bone and their degradation time can be controlled over a wide
range. However, the polymeric scaffolds show rapid strength degradation in vivo even
with high initial strength. Degradation of certain polymers (PLA, PGA) creates a local
acidic environment that can also have adverse tissue responses (Bose et al., 2012;
Rezwan et al., 2006).
1.5.2.4 Composites
Composites are those that are made of two or more distinctly different materials
such as ceramics and polymers with improved properties than its main components.
Development of an interconnected CaP-polymer scaffold takes advantages of both CaP
and polymers to meet mechanical and physiological requirements of the host tissue.
Polymers increase toughness and compressive strength of the produced composite
scaffold, thus making them similar to bone. Similarly, mechanical integrity and
bioactivity of polymers can be improved adding CaP (Arrington et al., 1996; Bose et
al., 2012).
The HAp/polyurethane (PU) composite scaffolds are also known to adsorb
higher amounts of bovine serum albumin (BSA), bovine fibrinogen, and fetal calf
serum (FCS) in vitro compared to PU scaffold. The micro-computed tomography
(mCT) reconstruction study showed that a 200 mm sized porous HAp/PU scaffolds
with 90±2% volume fraction porosity could be fabricated using traditional salt
leaching/phase inversion process. Even a surface modification of BCP porous scaffold
with HAp/PCL composite has been shown to increase the compressive strength by a

26
factor of two. Surface modification has been also shown to encourage differentiation
of primary human bone derived cells, with substantial upregulation of osteogenic gene
expression. Polymer/bioglass composite scaffolds also have shown promise in bone
tissue engineering. A nanocomposite of collagen and bioglass have shown early
mineralization within 3 days of immersion in SBF along with increased alkaline
phosphatase (ALP) expression after 21 days of culture (Bose et al., 2012; Zheng et al.,
2019).
Although various polymeric materials are available and have been investigated
for bone tissue engineering, no single biodegradable polymer can meet all the
requirements for bone tissue engineering scaffolds. Each polymer material has its own
characteristic advantages and disadvantages. On the other hand, composite materials
often show an excellent balance between strength and toughness and usually improved
characteristics compared to their individual components. As a matter of fact, natural
bone matrix is an organic/inorganic composite material of collagen and apatites. From
this point of view, composite materials are better choices as bone tissue engineering
scaffolds. It is well established that hydroxyapatite (HAp) mimics the natural bone
mineral and has been found to possess good mechanical and osteoconductive
properties (Liu & Ma, 2004; R. Zhang & Ma, 1999).
1.5.3 Techniques Used in Scaffolds Fabrication
Through the years a series of processing techniques such as solvent casting,
phase inversion, fiber bonding, melt based technologies, high pressure-based methods,
freeze drying, and rapid prototyping technologies were developed with the aim of
producing scaffolds with adequate properties for bone tissue engineering. A
description and discussion on these techniques will be given in the following lines
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(Salgado et al., 2004).
1.5.3.1 Thermally Induced Phase Separation (TIPS)
3D resorbable polymer scaffolds with very high porosities (97%) can be
produced using the TIPS technique (as shown in Figure 5) to give controlled macroand microstructures suitable as scaffolds for tissues such as nerve, muscle, tendon,
ligament, intestine, bone, and teeth. The obtained scaffolds are highly porous with
anisotropic tubular morphology and extensive pore interconnectivity. Microporosity
of TIPS produced foams, their pore morphology, mechanical properties, bioactivity
and degradation rates can be controlled by varying the polymer concentration in
solution, volume fraction of the secondary phase, quenching temperature and the
polymer and solvent used as discussed in a previous review paper (Nam & Park, 1999;
Rezwan et al., 2006).

Figure 5: The principle of thermally induced phase separation technique.

TIPS fabricated P(D,L-LA) foams with and without bioglass additions have
been shown to exhibit mechanical anisotropy concomitant with the TIPS-induced pore
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architecture. Polymer matrix composite films containing nanosized titania and other
inorganic particulate inclusions have demonstrated enhanced cell adhesion and a
tendency to increased Ca-containing mineral deposition. Recently, 3D PDLLA foams
containing both titanium dioxide (TiO2) nanoparticles and bioglasss additions have
been synthesized by TIPS. These foams demonstrate enhanced bioactivity and surface
nanotopography (Rezwan et al., 2006; Yunos et al., 2013).
The pore morphology of the scaffolds varies depending on the polymer,
solvent, concentration of the polymer solution and phase separation temperature. One
advantage of this method is that the fabricated scaffolds often have good mechanical
properties. For example, a PLA scaffold fabricated using a solid–liquid phase
separation technique has a modulus approximately 20 times higher than that of the
scaffold fabricated using the well-documented salt-leaching technique from the same
polymer and with the same porosity. However, this method usually generates scaffolds
with a pore size of 10–100 𝜇m, which may not be ideal for osteoblastic cell seeding
and bone tissue growth. Using a coarsening process in the later stage of thermally
induced phase separation, macroporous scaffolds with a pore diameter greater than
100 𝜇m can be generated (Jones et al., 2009; Liu & Ma, 2004).
1.5.3.2 Solvent Casting and Particle Leaching
Solvent casting of biocomposite scaffolds involves the dissolution of the
polymer in an organic solvent, mixing with ceramic particulates, and casting the
solution into a predefined 3D mold. The solvent is subsequently allowed to evaporate.
The main advantage of this processing technique is the ease of fabrication without the
need of specialized equipment. The primary disadvantages of solvent casting are: (1)
the limitation in the shapes (typically flat sheets and tubes are the only shapes that can
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be formed); (2) the possible retention of toxic solvent within the polymer; and (3) the
denaturation of the proteins and other molecules incorporated into the polymer by the
use of solvents. The use of organic solvents to cast the polymer may decrease the
activity of bioinductive molecules (e.g. protein). The detailed processing steps have
been described in the literature. Polymer-ceramic constructs can also be fabricated by
the solvent aggregation method. The polymer microspheres are first formed from
traditional water oil/water emulsions (Prasad et al., 2017; Rezwan et al., 2006). Figure
6 shows a schematic representation of the process of solvent casting and particle
leaching.

Figure 6: The principle of solvent casting and particle leaching technique.

Solvent casting/particulate leaching is probably the best known and most
widely used method for the preparation of bone tissue engineering scaffolds. It was
first described by Mikos et al. in 1994. This method consists in dispersing calibrated
mineral (e.g., sodium chloride, sodium tartrate and sodium citrate) or organic (e.g.,
sucrose) particles in a polymer solution. Yoon et al. reported that effervescent salts
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such as ammonium hydrogen carbonate and citric acid could also be used. This
dispersion is then processed either by casting or by freeze-drying in order to produce
porous scaffolds. This technique has been validated for PLLA or PLGA, for which
chloroform and methylene chloride were used. However, and as long as it is possible
to find an adequate solvent, this technique can be applied to other polymers, as reported
by Gomes et al. Scaffolds produced by this methodology have been used in several
studies for bone tissue engineering proposes, with relatively good results. However,
this method presents some disadvantages such as the use of highly toxic solvents and
the limitation to produce membranes up to 3 mm thick. Furthermore, their mechanical
properties are far from being ideal even when compared to those from trabecular bone
(Salgado et al., 2004; Q. Yang et al., 2006).
1.5.3.3 Solid Freeform Fabrication Techniques (SFFT)
SFFT, such as fused deposition modeling, have been employed to fabricate
highly reproducible scaffolds with fully interconnected porous networks. Using digital
data produced by an imaging source such as computer tomography or magnetic
resonance imaging enables accurate design of the scaffold structure. Solid freeform
(SFF) manufacturing coupled with conventional foam scaffold fabrication procedures
(phase separation, emulsion-solvent diffusion or porogen leaching) may be used to
develop scaffolds with controlled micro- and macroporous structures. Such
biomimetic internal architectures may prove valuable for multi-tissue and structural
tissue interface engineering (Leong et al., 2003; Rezwan et al., 2006). Figure 7 shows
a schematic representation of the SFF process.
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Figure 7: A schematic representation of the solid freeform fabrication technique.

To the authors’ knowledge, there is no literature available on degradable
polymer/bioactive glass composites made by SFFT. This technique has been only
applied for composites containing calcium phosphates as the bioactive phase. For
example, Xiong et al. fabricated composites of PLLA/TCP with porosities of up to
90% and mechanical properties close to human cancellous bone by using lowtemperature deposition based on a layer-by-layer manufacturing method of SFF
fabrication (computer-driven by 3D digital models). PLLA was dissolved in dioxane
and TCP powder mixed to prepare a slurry, which was formed into frozen scaffolds,
and subsequently freeze-dried. Alternate parallel layers formed macropores (400 𝜇m
diameter) and sublimation of the solvent during freeze-drying formed micropores (5
𝜇m diameter). Taboas et al. produced PLA scaffolds with computationally designed
pores (500–800 𝜇m wide channels) and solvent-derived local pores (50–100 mm wide
voids or 5–10 mm length plates). Indirect fabrication using casting in SFF molds
provided enhanced control over scaffold shape, porosity and pore architecture,
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including size, geometry, orientation, branching and interconnectivity. A shortcoming
of this route is increased scaffold fabrication time compared with direct methods, as a
temporary mould must be made first (Rezwan et al., 2006).
1.5.3.4 Microsphere Sintering
In this process, microspheres of a ceramic and polymer composite are
synthesized first, using emulsion/solvent evaporation technique. Sintering the
composite microspheres yields a 3D, porous scaffold. 3D composites of degradable
polymers and bioactive glass have been produced by sintering composite microspheres
by Lu et al. in a scientific research. Starting materials were PLGA-bioglasss composite
microspheres obtained through a water–oil–water emulsion technique. Sintering of the
microspheres into cylindrical shapes resulted in a well-integrated interconnected
porous structure, with the microspheres joined at the contact necks. Average porosity
was 40% with pore diameters of 90𝜇m, and mechanical properties close to cancellous
bone. The composites were shown to be bioactive as a calcium phosphate layer formed
on the surface of the composite on immersion in SBF for 7 days. Moreover, bioglasss
reinforcement gave a two-fold increase in compressive strength. The scaffolds were
shown to support the adhesion, growth and mineralization of human osteoblast-like
cells in vitro. Over a 3-week period, cultures with PLGA/bioglasss maintained pH
variations within physiological ranges. More recently, Yao et al. synthesized
PLGA/bioactive glass microspheres by emulsification and heated them in molds to
fabricate porous 3D scaffolds. They demonstrated the bioactivity of the composites
and their ability to promote osteogenesis of marrow stromal cells (Brown et al., 2008;
Rezwan et al., 2006). Figure 8 shows a schematic representation of the microsphere
sintering technique.
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Figure 8: A schematic representation of microsphere sintering technique.

1.5.3.5 Electrospinning
This is a unique process for producing fibers with nanoscale diameters using
high electric field. In this process, a polymer viscous solution in a capillary is subjected
to an electric field generated by high voltage. A polymer jet is ejected from the
capillary when the electric field overcomes the surface tension. Accordingly, the jet
travels toward a grounded collector and deposit in the form of unwoven fibers that are
deposited on the collector in the form of a nonwoven fabric (C. Li et al., 2006; Teo &
Ramakrishna, 2006). By adjusting the solution properties and various operating
parameters, fibers with different dimensions and overall scaffold porosities can be
controlled during electrospinning. These features make this approach promising,
especially for the fabrication of tissue-engineered scaffolds. Moreover, the
convenience of incorporating various nanomaterials into the electropsun polymer
solutions makes it attractive for various biomedical applications at large. A broad
range of materials, from natural polymers and recombinant proteins, to synthetic
polymers, have been processed into porous scaffolds for studies in biomaterials tissue
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engineering using electrospinning technique (Lannutti et al., 2007). Figure 9 shows a
schematic representation of the electrospinning technique.

Figure 9: A schematic representation of the electrospinning technique.

1.5.3.6 Gas Foaming Process
This process can be used to fabricate highly porous polymer scaffolds without
the use of organic solvents. In this approach, carbon dioxide (CO2) is usually used as
a foaming agent for the formation of a foam. In this process, solid polymer disks are
exposed to high pressure CO2 stream to allow saturation of CO2 in the polymer. As a
result, thermodynamic instability is then created by rapidly releasing CO2 gas from the
polymer system, followed by the nucleation and growth of gas bubbles in the material.
Polymer foams with a pore size of 100 m and a high porosity up to 93% can be
fabricated using this approach. The disadvantage of this method is that it yields mostly
a nonporous surface with a closed-pore structure (Mohammed, 2016). An example is
shown in the work of Money et al., where they obtained PLGA scaffolds with 93% of
porosity and a pore size in the range of 100 m. Although scaffolds produced by this
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route have shown to support osteoblast-like cells growth, deposition and
mineralization of bone ECM-like matrix, the method has a number of disadvantages
such as the relatively low mechanical properties, the presence of non-porous and
closed pore structures, which may be problematic for cell and tissue in growth
(Culmone et al., 2019; Joshi et al., 2015). Figure 10 shows a schematic representation
of the gas foaming technique.

Figure 10: A schematic representation of the gas foaming technique.

1.5.3.7 3D Printing
The 3D porous structures of biomaterials can eventually accelerate the process
of bone ingrowth through interconnected pores. However, it is difficult to maintain
high interconnectivity of porosity within well-designed 3D porous scaffolds using the
aforementioned fabrication methods. Accordingly, additive manufacturing techniques
including 3D printing have been developed in recent years as an alternative approach
towards the fabrication of porous scaffolds. Customized porous scaffolds can be
produced by 3D printing with predesigned architecture and inner architecture (C. Yang
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et al., 2018; Guvendiren et al., 2016).
3D printing was the first technique to be proposed for biomedical and tissue
engineering applications. This particular technique employs inkjet technology for the
processing powder materials. In this method, a printer head is used to print a liquid
binder onto thin layers of powder, as dictated by the object’s profile that is generated
by a computer-aided design (CAD) model. The subsequent piling and printing of
material layers to the top of previously printed layer recreates the final full structure
of the desired scaffold. This process is performed at room temperature, which allows
for the eventual incorporation of growth factors and other biomolecules that will help
with the tissue engineering application for the printed scaffold. Scaffolds using
different materials and various morphologies have been fabricated using this
technique, showing good cell–material interactions. The main disadvantage of this
technique is the dependence of the pore size of the fabricated scaffolds on the particle
size of the stock powder material. Moreover, other disadvantages include closure of
the pores by the stock material, and the required use of organic solvents as binders.
Furthermore, and because the final structure is a combination of several stack up
powdered layers, the mechanical properties can also be a problem (Salgado et al.,
2004; Wijk & Wijk, 2015). The current sections will outline the different approaches
of 3D printing that have been explored for the manufacturing of porous scaffolds for
different applications.
1.6 3D Printing Technology
3D printing is a layer-by-layer fabrication of objects, and sometimes referred
to as rapid prototyping (RP) or additive manufacturing (AM). This technique was first
adopted as an advanced manufacturing technology at the Nagoya Municipal Industrial
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Research Institute in 1981. Since then, an excessive interest in this technology has
been developed due to the complexity and diverse functionality of industrial products.
Figure 11 outlines the various types of 3D printing approaches that have been realized
since then. Recent advances have opened the door to explore the importance of 3D
printing for the fabrication of novel materials including nanomaterials for various
applications (Balogun et al., 2019; Y. Yang et al., 2018).

Figure 11: Schematic of various 3D printing technologies.

AM was originally invented for the sake of building 3D objects that are made
of metals, ceramics and polymers, so that complex parts of these materials can be
made. Among the first studies on AM technique, the fabrication of 3D objects from
polymers was based on the photo-polymerization processes in which ultraviolet
curable polymers were used for printing multi-layers of solid constructs (Godoi et al.,
2016). On the other hand, a basic 3D printing process is a controlled robotic-process,
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where a product is built up layer by layer from a 3D computer design program CAD
or by downloading 3D platforms from various available resources, such as
Thingiverse, Shapeways, Ponoko or Sculpteo. A CAD-created 3D model is then
forwarded to the printer, which in turn slices the 3D model into layers and assembles
them in the specified cross section pattern of the final scaffold (Bhargav et al., 2017;
Dankar et al., 2018).
The choice of materials for 3D printing is directly related to the technology
used. These are polymer-based, metal-based, and ceramic-based. These are
summarized in Figure 12.

Figure 12: Fabrication of biomedical materials using 3D printing technology.
(a) Percentages of different polymeric-based materials used to print medical instruments (see text for
abbreviations); (b) percentages of different metallic materials used to print medical instruments; (c)
percentages of different categories of materials used to print medical instruments (Culmone et al., 2019).

The group with the largest number of applications (86%) is that of polymerbased materials. Polymer-based materials include acrylonitrile butadiene styrene
terepolymer (ABS), poly(lactic acid) (PLA), poly(ethylene terephthalate (PET),
polyamides (nylon), polycarbonates (PC), resins, and rubber-like materials. The main
application of polymer-based materials is partially related to biocompatibility, as for
PLA, and biodegradability as for PA2200 polyamides raw powder. Compared to
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polymer-based materials, metals are rarely used. Stainless steel (SS) is most commonly
used, while both titanium (Ti) alloy cobalt–chromium (Co–Cr) alloy are used in a
limited number of applications Ceramic-based materials are used in a small number of
applications, including ceramic-filled epoxy resin and alumina-zirconia composite and
in the personalized tools for tracheostomy (Bekas et al., 2019; Culmone et al., 2019).
1.6.1 Material Jetting and Extrusion
Material jetting is an AM technique that is based on the principle of customary
paper printing. It involves an extension that utilizes light curable resins instead of the
common (usual) inks. In this technique, solutions can be printed on different substrates
as the ink of photopolymer resin is dropped over time to create a layer-by-layer design
of the intended mold. This method can best be suitable for the fabrication of flat-sheet
polymer membrane and are usually used in the fabrication of novel membranes, where
conventional methods are not forthcoming. Through the process of material extrusion,
the material is forced-out through a print head, a nozzle, thus applying a constant
pressure on the printing platform. The extruded material is then deposited, and solidify.
The process continues until the final prototype is obtained (Yap et al., 2017).
This technique includes fused deposition modeling (FDM) and direct laser
writing (DLW), where the technology that operates by material extrusion principles of
3D printing is the FDM. In FDM, a thermoplastic polymeric filament is heated beyond
its glass transition temperature (Tg) followed by its extrusion via a mobile print
(nozzle) head controlled by artificial intelligence. The head deployed the printing
material, layer by layer, on a printing surface which immediately solidifies under a
pre-adjusted and controlled temperature, followed by the assembling of the layers to
form a 3D final architecture (Balogun et al., 2019). A schematic of the process is
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shown in Figure 13. FDM has been mostly identified with desktop low-cost 3D
printers, which are considered as the most simplified additive manufacturing process
(Bass et al., 2015; Zolfaghari et al., 2019).
.

Figure 13: Schematic of fused deposition modeling and direct laser writing.

The current work deals with the development of 3D printed porous scaffolds
followed by their chemical functionalization to enhance their application as bone
substitution implants.
1.6.2 3D printing for Biomedical Applications
The technology of 3D printing has been recently used for biomedical
applications. Examples include the fabrication of pathological organ models to help
during the planning and analysis of surgical treatment (Butscher et al., 2013), the
fabrication of bioinert implants, the fabrication of interactive bioactive and
biodegradable scaffolds, as well as the 3D printing of tissues and organs with complete
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life functions (Derby, 2012; Saunders et al., 2008; Xu et al., 2013). These applications
are not widespread.
Compared with fabricating implants by means of traditional technologies, 3D
printing can achieve personalized real-time manufacturing of any complex implant
with high dimensional accuracy and short production cycles. An example is in the
traditional bone treatments, where stress-shielding phenomena can easily occur
because traditional metallic implants present greater stiffness than bone, which will
eventually compromise bone integrity. In this regard, integrating topologyoptimization designs with 3D printing is a new and effective technology to fabricate
lightweight customized implants with adjusted stiffness (Al-Tamimi et al., 2017). An
advantage arises here, where 3D printing technology is highly compatible with digital
measuring devices that have been widely used, in terms of data conversion and space
docking.
It should be mentioned that the maturity of the current technology of 3D
printing permanent implants has resulted in the development of medical materials for
higher performance (Yan et al., 2018). Examples included the 3D fabrication of
titanium (Ti) (Winder et al., 1999) and HAp-coated Ti (Peng et al., 2008) as well as
nanostructured Ti onto a Ti6Al4V alloy (Izquierdo-Barba et al., 2015). On the other
hand, 3D printing technology has been successfully used for the fabrication of
bioactive and biodegradable scaffolds (Yan et al., 2018). In this regard, two
approached have been explored. In the first approach, a porous scaffold is made by 3D
printing, then seeded with cells (Langer & Vacanti, 1993), either alone or in
combination with other biocompatible materials, such as growth factors, and physical
factors can be used to create a biomimetic tissue-like microarchitecture scaffold (S. Li
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et al., 2017). In the second approach, both cells and materials are formulated into a
composite structure (Wolfe et al., 2010), where a mixture of cells and gel is
encapsulated into 3D scaffolds that are composed of another kind of gel with good
mechanical strength, or are printed directly in order to control the spatial distribution
of cells and even realize in situ repair.
Materials used for 3D printing of medical implants include ceramics, metallic
or polymeric (Yan et al., 2018). Polymeric materials, either natural or synthetic
biomaterials, are used. Examples of natural polymers include chitosan, collagen, and
fibrin, which possess excellent compatibility, promote cell adhesion and proliferation,
and maintain cell phenotypes. On the other hand, synthetic polymers such as PLA,
PVA, and PCL have been explored (Xu et al., 2012). PLA is one of the most commonly
used materials in the biomedical sector because of its processability, mechanical
properties and biocompatibility, and has been explored for 3D printing of biomaterials
(Donate et al., 2020). Poly(ethylene terephthalate) (PET) has been also explored in 3D
printing of medical devices after being augmented with calcium phosphate ceramics
(Sandler et al., 2011). On the other hand, other polymers which are relatively bioinert,
such as acrylonitrile-butadiene-styrene (ABS) terpolymer are used for creating
medical models for perioperative surgical planning and simulations (Shen et al., 2017).
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Chapter 2: Aims of the Study

The aims of the current study are to:
1. Use 3D printing technology to develop porous scaffolds with a pre-designed
architecture, followed by their characterization in terms of their structure and
morphology.
2. Investigate the possibility of chemically functionalize the surfaces, internal
and external, of the 3D porous scaffolds using various approaches.
3. Characterize the chemically-functionalized 3D porous scaffolds in terms of
their structure and morphology.
4. Evaluate the chemically-functionalized 3D printed porous scaffolds for their
preliminary in vitro applications.
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Chapter 3: Materials and Methods
3.1 Materials
3.1.1 Materials Used for 3D printing
These included 3 types of polymeric filaments; PLA, PET, and ABS. Their
manufacturer’s specifications are given in Table 1.
Table 1: Specifications of polymeric filaments used in the current study.
PLA

PET

ABS

Manufacturer

Ultimaker

The3DBee

The3DBee

Diameter

2.85 mm

2.85 mm

2.85 mm

Color

Transparent

Clear

Natural

Print Temperature

195-240℃

195-220℃

240-260℃

Bed Temperature

60℃

35-60℃

80℃

3.1.2 Materials Used for Chemical Functionalization of 3D Printed Scaffolds
These included: sodium hydroxide (NaOH), sodium chloride (NaCl), sodium
bicarbonate (NaHCO3), potassium chloride (KCl), dipotassium hydrogenphosphate
(K2HPO4), magnesium chloride (MgCl2), calcium chloride (CaCl2), sodium sulfate
(Na2SO4),

Copper(II)

nitrate

trihydrate

(Cu(NO3)2.3H2O),

tris

buffer

((CH2OH)3CNH2), 1,3,5-benzenetricarboxylic acid (trimesic acid), triethyl amine
(TEA), HCl, ethanol, and acetone. All chemicals were analytical-grade and were
obtained from Sigma-Aldrich, USA and used as received.
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3.2 3-D printing Setup
An Ultimaker 2+ 3D printing machine (ULTIMAKER 2+, USA) was used for
the 3D printing of PLA, PET and ABS porous scaffolds. The 3D printer has overall
dimensions of 35.7 X 34.2 X 38.8 cm, while its build plate dimensions are 22.3 X 22.3
X 20.5 cm. The supported File used in this printer is STL (Ultimaker Cura 3.0.4
software). Figure 14 and Table 2 show a detailed description of the Ultimaker 2+ 3D
printer used in the current study.

Figure 14: Front and back views for 3D printer used (Ultimaker 2+).
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Table 2: Identification for the labeled items of Ultimaker 2+ shown in Figure 14.
1

SD card slot

9

Print head cable

2

Display

10

Spool holder

3

Push/rotate button

11

Power connector

4

Build plate screws

12

USB connector

5

Build plate clamps

13

Power switch

6

Build plate

14

Feeder

7

Print head

15

Print head cable

8

Bowden tube

16

Bowden tube

3.3 Methods and Procedures
3.3.1 Printing 3D Porous Scaffolds Using Ultimaker 2+ 3D Printer
A CAD design was made using Solid Works software, so that the porous
scaffold contains interconnected porosities. Disks that are 0.5 inch in diameter and
0.25 inch in thickness were designed, as schematically represented in Figure 15. The
diameter of each of the surface and side pores was 0.05 inch.

Figure 15: A CAD design of the 3D porous scaffolds that were printed using the
Ultimaker 2+ 3D printer.
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Following the design of the 3D scaffolds, it was saved as STL file, which was
then introduced to the Ultimaker 2+ software (CURA 3.0.4) for slicing. Table 3 shows
the Ultimaker 2+ setup conditions that were maintained throughout the printing
process. Prior the onset of the printing process, a thin layer of glue was applied on the
surface of the build plate to ensure the static positioning of the printed objects
throughout the printing process. Each of the selected filaments was placed in positions
10 and 14 (Figure 14), and the 3D printer software was run to ensure the intrusion of
the filament within the feeding tube in positions 15 and 16 and then to the nozzle in
position 7 (Figure 14). Based on the type of polymeric filament, the operating printing
conditions were selected, as shown in Figure 16. An estimated duration of the printing
process was given by the printer, after which the printed scaffolds were collected.
Figure 17 shows the 3D printing process and an image of the collected 3D porous
scaffolds.
Table 3: Specifications of the 3D printer used (Ultimaker 2+).
Specification

Parameter / Value

Nozzle

Size: 0.25 mm

Quality

Layer height: 0.06 mm

Shell

Wall thickness:0.88 mm
Top/bottom thickness: 0.72 mm

Infill

Infill Density: 22%
Gradual Infill Steps: 0

Speed

Print Speed: 20 mm/s
Travel speed: 100 mm/s
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Figure 16: Operating 3D printing conditions of ABS, PLA and PET filaments.
(CPE+ was used as the closest structure to PET based on the manufacturer recommendations).

Figure 17: An image of 3D printing process and for typical 3D printed scaffolds.

3.3.2 Chemical Functionalization of 3D Printed Porous Scaffolds
All 3D printed porous scaffolds were subjected to chemical functionalization
using variable approaches. Both PLA and PET printed scaffolds were functionalized
through alkaline treatment, while PLA, PET and ABS printed scaffolds were
functionalized through solvent conditioning. Details of these processes are described
below.
3.3.2.1 Alkaline treatment
The main objective of this process was to create functional groups onto the
surfaces of PLA and PET through the treatment with highly basic media. This is based
on the fact that polyesters are expected to undergo alkaline hydrolysis upon the
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exposure to highly alkaline media. In this experiment, a highly basic NaOH aqueous
solution (5M) was prepared to be used for the alkaline treatment of PLA and PET
porous scaffolds. Dry scaffolds were placed in the basic solution for 1, 6 and 12 hours
with continuous stirring. Samples were removed, thoroughly washed with deionized
water and dried for 24 hours in moderate temperature or even in air. A schematic
diagram and flowchart of the process are shown in Figures 18 and 19.

Figure 18: Schematic diagram for alkaline treatment process.

Figure 19: Alkaline treatment process flow chart.

50
3.3.2.2 Solvent Conditioning
The main objective of this process was to decrease the surface roughness of the
PLA and PET porous scaffolds through the careful dissolution and fusion of the asprinted groves onto the surfaces of the scaffolds. In this regards, PLA and PET
scaffolds were conditioned by exposing them to acetone vapor for 6 hours. Figure 20
shows an image of the experiment setup, and Figure 21 shows a flow chart showing
the process of smoothening done on the process scaffolds.
A direct contact of the scaffolds with acetone was avoided to prevent the
dissolution of the scaffolds. It should be mentioned that surface treatment using solvent
exposure was carried out to the as-printed, as well as alkaline-treated PLA and PET
porous scaffolds.

Figure 20: An image of the experimental setup for the solvent conditioning of the PLA
and PET porous scaffolds.
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Figure 21: A flow chart showing the process of smoothening of a 3D printed scaffold.

On the other hand, the internal and external surfaces of the ABS porous
scaffolds were conditioned through the treatment with a 1:1 ethanol:water solvent
mixture for 6 hours. Wetting of the surfaces of the ABS scaffolds with this solvent
mixture was attempted before coating them with metal-organic framework
functionalities, as will be detailed later.
3.3.3 Evaluation of the preliminary in vitro characteristics of PLA and PET
scaffolds
This process was carried out via a biomimetic process where PLA and PET
porous scaffolds, both as-printed and surface treated, were immersed in a protein-free
simulated body (SBF) fluid for up to 21 days. The morphological development of a
bone-like apatite layer onto and the surfaces and into the pores of the PLA and PET
porous scaffolds is an indication of the suitability of the scaffolds to be used as
potential biomaterials, hence considered a preliminary in vitro evaluation of the 3D
printed scaffolds.
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3.3.3.1 Preparation of 1.0 SBF and 1.5 SBF
A protein-free SBF medium was prepared using inorganic salts that provide
ions with concentrations similar to those in a human physiologic medium. Two
solutions were prepared; called 1.0 and 1.5 SBF, where the latter contains 1.5 times
the concentrations of the same ions. Table 4 shows the composition of both 1.0 and
1.5 SBF media. These media are supersaturated with respect to bone-like apatite
precipitation, which will take place upon the availability of certain functional groups
similar to those present along natural collagen fibers. This is the reason behind naming
the process “biomimetic”, where the process simulated the natural biomineralization
process where natural bone apatite crystallites, which is calcium phosphate in nature,
deposit and grow onto the surfaces of collagen nanofibers.

Table 4: Ionic concentrations of 1.0 SBF and 1.5 SBF media, as compared with those
in human physiologic plasma.
Na+

K+

Ca2+

Mg2+

HCO-3

Cl-

HPO42- SO42-

Blood Plasma

142.0

5.0

2.5

1.5

27.0

103.0

1.0

0.5

1.0 SBF

142.0

5.0

2.5

1.5

4.2

148.0

1.0

0.5

1.5 SBF

213.0

7.5

3.8

2.3

6.3

222.0

1.5

0.8

Both 1.0 and1.5 SBF media were prepared using the same procedure, where
the respective reagents of these ions were added in a certified sequence to deionized
water at room temperature. The pH of the final 1.0 and 1.5 SBF media was adjusted at
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7.2 ± 0.05 using a tris buffer and as followed by an Orion pH meter. Upon the complete
preparation of both media, they were stored at 10oC until used.
3.3.3.2 Biomimetic treatment of Porous Scaffolds in SBF Media:
A number of parameters were studied in this process, these are summarized as
follows:
a) Type of scaffold: PLA and PET.
b) Surface roughness: as-printed (rough) and solvent-treated (smooth).
c) Chemical treatment: as-printed, and alkaline treated for 1 and 6 hours.

Figure 22 summarizes these parameters. Three porous scaffold disks
representing each parameter were soaked in 1.0 SBF media (50 ml), coated with
parafilm with a punched surface to allow exchange of humidity between the interior
and exterior of the tubes. All tubes were maintained in an incubator with 100% relative
humidity and 37.5oC to imitate the physiologic conditions. All media containing
scaffolds were soaked for up to 21 days with a continuous shaking at a speed of 100
rpm. An aliquot of 3 ml was collected every day and stored in a closed test tubes until
analyzed. Samples representing each parameter were left in 1.0 SBF for one, two and
three weeks, followed by one week in a 1.5 SBF medium. Figures 23 and 24 are
showing the timetable setup of this experiment and a schematic for the experimental
procedure steps. After the end of each time point, scaffolds were collected, washed
with deionized water then dried in air to be characterized.
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Figure 22: Schematic of samples' specifications used in the biomimetic process.

Figure 23: Detailed timetable of the biomimetic process.

Figure 24: Detailed schematic of biomimetic process in SBF & 1.5SBF media.
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3.3.3.3 Impregnation of PLA and PET scaffolds
Impregnation, filling the empty voids, of PLA and PET porous scaffolds was
carried out at room temperature. The inclusion of a pre-prepared bone-like apatite
within the interconnected pores of PLA and PET, both as-printed and alkaline-treated,
was attempted so that they can be used for partial replacement of cancellous bone. A
30 weight% stable slurry containing hydroxyapatite (HAp) in deionized water was
made by dissolving the respective mass of HAp. A commercially available dispersing
agent; known as Duramax, was introduced to facilitate the dispersion of the HAp
particulates in water so that a stable slurry was obtained. Samples representing the asprinted, alkaline treated for 1 and 6 hours of PLA and PET were soaked in the HAp
slurry in a glass beaker, which was then placed in vacuum desiccator and subjected to
vacuum. This process was continued until air bubbles formation was stopped, which
indicated the impregnation of the porous scaffolds with the slurry. Figure 25 shows a
schematic representation of the process and Figure 26 shows a flow chart for the
general steps. Impregnated scaffolds were collected, left to leach out the unimpregnated slurry and dried in air for 48 hours. Dried impregnated scaffolds were
characterized for their morphology.

Figure 25: A schematic representation of the impregnation process.
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Figure 26: Flow chart of the impregnation (HAp coating) process.

3.3.4 Formation and Growth of HKUST-1 onto/into ABS porous scaffolds
HKUST-1 is a type of metal-organic framework which is based on a 3D
hierarchical structure of copper ion (Cu2+) clusters and benzene tricarboxylate (also
known and trimesic acid; TMA) organic linker. HKUST-1 preparation takes place at
room temperature by mixing solutions containing the Cu2+ ions and TMA. Assembly
of the HKUST-1 hierarchical structure takes place spontaneously giving rise to a navyblue color precipitate.
Two solutions; solution A containing TMA and triethylamine (TEA) and
solution B containing Cu2+ ions were prepared in a solvent mixture containing absolute
ethanol and deionized water (1:1 by volume). In a typical experiment, solution A was
made by dissolving 0.6636 g of TMA and 1.312 ml of TEA in a 60 ml of solvent
mixture, while solution B was made by dissolving 1.068 g of Cu(NO3)2.3H2O. Both
solutions (A & B) were mixed with continues stirring for 4 hours, after which a
suspension of HKUST-1 was formed. To separate the HKUST-1 precipitate, each
slurry was centrifuged at a speed of 3000 rpm, and filtered overnight at room
temperature. Atypical experimental procedure is shown in Figure 27.
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Figure 27: A typical experimental setup showing the precipitation and filtration of pure
HKUST-1 powder.

Formation of HKUST-1 onto/into ABS porous scaffolds was carried out using
a layer-by-layer approach where the process of deposition of HKUST-1 was carried
out on stages. Each stage was represented by the deposition of an organic linker
(TMA/TEA) layer, followed by Cu2+ ions layer. Each stage was carried out for 4 hours,
following the procedure described above for pure HKUST-1. A total of 8 cycles were,
therefore, carried out for the layer-by-layer deposition of HKUST-1 onto and into
porous ABS scaffolds. It should be mentioned that all ABS porous scaffolds used in
this experiment were previously conditioned by immersion in a 1:1 solvent mixture of
ethanol and water that is also used for the preparation of pure HKUST-1. At the end
of 4 complete stages (8 cycles), HKUST-1-coated ABS scaffolds were washed with
the same solvent mixture; and completely dried in air for 2 days to be analyzed.
In a parallel experiment, the above mentioned procedure was carried out using
a 2:1 (H2O:ethanol) solvent mixture in order to evaluate the variation, if any, of the
morphology of the precipitated HKUST-1 onto/into ABS porous scaffolds. A typical
schematic representation of the crystal structure of HKUST-1 is shown in schematic
of Figure 28.
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Figure 28: A flow chart showing the layer-by-layer deposition technique for the growth
of HKUST-1 onto a 3D porous ABS scaffolds.

3.4 Methods of Characterization
The following techniques were used for the characterization of the 3D printed
porous scaffolds as well as their evaluation for the growth of bone-like apatite and
HKUST-1 onto/into their porous structure.
3.4.1 Fourier-transform infrared spectroscopy (FTIR)
This was carried using a Perkin-Elmer FTIR spectrometer operating at a
wavenumber range of 400-4000 cm-1 in a reflectance mode. FTIR was carried out to
assess the variation in the functional groups of all types of scaffolds upon 3D printing
and after the various types of chemical treatment and functionalization described
above.
3.4.2 Thermogravimetric analysis (TGA)
Which was carried out using a shimadzu thermogravimeter over a range of 25800oC to assess the thermal history of the analyzed samples. TGA was mainly used to
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characterize the thermal events during the degradation and decomposition of the 3
polymeric filaments before being used for 3D printing.
3.4.3 X-ray diffraction (XRD)
This was mainly used to identify the phase composition of the chemically
formed HKUST-1 in the pure (bulk) form as well as onto the surfaces of ABS porous
scaffolds. A Regaku XRD instrument was used in this regard. It utilizes the diffraction
of X-rays generated from a Cu target with a wavelength of 1.5404 Å within a 2 range
of 5-90oC.
3.4.4 Scanning electron microscopy & Energy-dispersive x-ray analysis (SEMEDX)
SEM was extensively used throughout this study to evaluate the development
of microstructure at different magnifications of all scaffolds as a result of all various
types of treatments described above. EDX was used for the elemental analysis of the
bone-like apatite coating onto PET and PLA scaffolds, as well as the HKUST-1
coating onto the ABS porous scaffolds.
3.4.5 Inductively-coupled plasma-atomic emission spectroscopy (ICP-AES)
This is an elemental analysis technique that was used to analyze the variation
in the concentrations of Ca2+ and PO43- ions in the collected SBF aliquots at different
time points as a result of the immersion of as-printed and alkaline-treated rough and
smooth PLA and PET porous scaffolds.
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Chapter 4: Results and Discussion

4.1 Characterization of as-Printed Pristine Scaffolds
Porous scaffolds of all three polymers were fabricated using 3D printing of
their respective polymeric filaments. Solid 3D printed scaffolds were characterized for
their composition and morphology using infrared spectroscopy, Thermogravimetric
analysis, optical microscopy and scanning electron microscopy, as will be discussed
in the following sections.
Figureswe 29 and 30 show IR spectra of the as-printed pristine scaffolds. The
major characteristics bands of all polymers are shown on the spectra. Both PLA and
PET are designated as polyesters, as shown in Figure 29. Hence their IR spectra
contained bands that are characteristic to C=O and C-O of a typical ester group at 1725,
and a doublet at 1080-1190 cm-1, respectively. Moreover, the IR spectrum of a PET
sample shows a broad low intensity band around 3300 cm-1, which could be attributed
to terminal –OH groups or physically attached water molecules. IR spectrum in Figure
30, on the other hand, showed the presence of all C-H and C=N bonds, both aliphatic
and aromatic, as previously observed in the chemical structure of ABS. Interestingly,
a clear band representing –C≡N, which is presumed to appear at 2240-2260 cm-1, was
not shown. Instead, a band was shown at 1719 cm-1 was observed, which could be
attributed to the stretching mode of the C=N bond. All IR spectra of the as-printed
polymers, therefore, indicate their phase purity.
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Figure 29: IR spectra of as 3D-printed PET and PLA scaffolds.

Figure 30: IR spectra of as 3D-printed ABS scaffold.

Figure 31 shows TGA thermograms of the as-printed pristine scaffolds. Each
scaffold showed a single thermal event due to the decomposition of the chains of the
polymers. All studies polymers are C,H,O-based, which means that their
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decomposition takes place through their combustion to CO2 and H2O. The presence of
a single thermal event also indicates the monodispersity of the molecular weight of all
polymers, where the homogeneity in the molecular weight of the polymers was
reflected in the absence of other thermal events due to variation in molecular weights.
PLA showed an earlier decomposition at 375.5oC with an onset temperature of 288oC,
as shown in Figure 32, while PET and ABS showed a comparable decomposition
temperature of 420.5 and 425.2oC, with onset temperatures of 350 and 288oC,
respectively. A complete burn out of both PLA and PET was achieved at 570 and
700oC, respectively, while ABS was completely burnt out above 700oC. Table 5 shows
the operating temperatures of the nozzle and the collection plate according to the
manufacturing guidelines. At the nozzle temperature, earlier softening of each of the
polymers results in its extrusion in the form of molten filaments that eventually deposit
in the form of the pre-designed scaffold.

Figure 31: TGA thermograms of as 3D-printed PET, PLA, and ABS scaffolds.
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Figure 32: DTG (1st derivative thermograms) of as 3D-printed PET, PLA, and ABS
scaffolds.

Table 5: Operating temperatures of the nozzle and collection plate.
ABS

PET

PLA

Nozzle Temperature (oC)

250

260

210

Collection plate temperature (oC)

80

110
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All as-printed pristine scaffolds were examined using an optical microscopy
(10x) to check their homogeneity and compatibility with their initial design. Figure 33
shows optical photographs of all printed scaffolds. Two main features were observed:
First, all scaffolds maintained their initially designed architecture with the
interconnected porosity. However, all scaffolds showed the presence of tiny filaments
within the open pores of the scaffolds, which are attributed to the transfer of the nozzle
during printing on the x-y plane while carrying the softened polymers. Second, ABS
scaffold showed a fine surface finishing compared with PLA and PET whose scaffolds
showed surface roughness.
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(a)

(b)

(c)

Figure 33: Optical photographs of the 3D printed scaffolds.
(a) ABS, (b) PET, and (c) PLA.

However, surface porosity was observed in all scaffolds with different
extents, with PLA showing the highest extent. These are referred to by arrows in Figure
34. Moreover, the layer structure shown extensively in Figure 34f, as a representative
microstructure, reflects the advance of the printed polymer as indicated by the grey
arrow in Figure 34e. The extent of surface roughness was more pronounced in the PLA
scaffold. A higher magnification study of all scaffolds confirmed the higher surface
roughness of the PLA scaffold, compared with both ABS and PET scaffolds, as shown
in Figure 34. For scaffolds to be used as total or partial replacement of defective hard
tissues, surface roughness is an advantage where better bonding with the surrounding
hard tissues is achieved, which results in a lower percentage of implant dislocation
after implantation (van Tol et al., 2013).
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(a)

(b)

(c)

(d)

(e)

(f)

Figure 34: SEM micrographs of 3D printed scaffolds at different magnifications.
(a&d) ABS, (b&e): PET, and (c&f): PLA.

4.2 Smoothening of 3D Printed Scaffolds
Despite the advantages or having scaffolds with rough surfaces for biomedical
applications, the effect of surface smoothening on the subsequent treatment of
scaffolds in simulated body fluids was evaluated. The process was carried out via the
direct exposure of the 3D printed scaffolds to acetone vapor for 6 hours. This is based
on the fact that subsequent exposure or direct immersion in acetone was found to
completely dissolve both scaffolds. Completely cleaned and dried PET and PLA
scaffolds were characterized for their structure and morphology using IR, optical and
scanning electron microscopies, respectively.
Figure 35 shows IR spectra of the smoothened scaffolds as compared with
those of the as-printed pristine scaffolds in Figure 29. Smoothened PET scaffold
showed a decrease in the intensity of the bands characteristics to the ester C-O group,
while maintained the band attributed to the ester C=O group. On the other hand, PLA
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smoothened scaffold showed the existence of all bands characteristic to the same
polymer, as shown in Figure 35 in comparison to Figure 29. It should be mentioned,
however, that both smoothened scaffolds showed the presence of two groups of bands
within the range of 400-525 and 3500-4000 cm-1, which are not attributed to the
structure of both polymers, and are hence attributed to possible contamination of both
samples during the smoothening process.

Figure 35: IR spectra of smoothened PET and PLA 3D scaffolds.

Smoothening has been shown to cause a refining of the surfaces of the
scaffolds, where fine marks resulting from 3D printing disappeared completely by
exposure to acetone vapor. Figure 36 shows the light reflection of the smoothened
scaffolds and decrease in the surface roughness of both PET and PLA scaffolds. These
findings were further confirmed by studying the microstructure of the smoothened
scaffolds as shown in Figure 37. Exposure of PET scaffolds to acetone vapor resulted
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in complete smoothening of the surfaces of the scaffolds, as shown in Figure 37a. On
the other hand, the high degree of roughness of the surfaces of the PLA scaffolds was
completely disappeared through the surface dissolution of the rough edges of the
surface layers after exposure to acetone vapor, as shown in Figure 37b. These are
referred to by white arrows in Figure 37b. Moreover, the exposure of the PLA scaffold
to acetone vapor refined the layer structure of the deposited layered scaffold, by
dissolving the weakly bound layers as shown in Figure 37b at higher magnification. It
should be mentioned, however, that mechanical integrity of the scaffolds were
maintained, where exposure of both types of polyesters to acetone did not affect their
intact structure, as shown in Figure 36.

(a)

(b)

Figure 36: Optical photographs of as-smoothened 3D printed scaffolds.
(a) PET and (b) PLA.
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(a)

(b)

Figure 37: SEM micrographs at different magnifications of PLA and PET assmoothened 3D printed scaffolds.
(a) PET and (b) PLA.

4.3 Alkaline Treatment of 3D Printed Scaffolds
Polyesters, such as PLA and PET are essentially made by condensation of dicarboxylic acids and di-hydroxy compounds. Having an ester linkage within a
polymeric chain can be therefore hydrolyzed using strong alkalies. Normally, this
process yields free carboxy- and hydroxy-carrying species, and may lead to a
degradation of the polymer. In the current study, alkaline treatment of PET and PLA
porous scaffolds was carried out using 5M NaOH solution for 1 and 6 hours to evaluate
the extent of hydrolysis, so that a complete breakdown of the polymeric structure of
the scaffold is avoided (see alkaline treatment process as a chemical hydrolysis in
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Figure 38). Surface treatment of PET and PLA in alkaline media are, therefore,
intended to generate functional groups on the surfaces of these scaffolds, hence
improve their eventual affinity towards the preliminary evaluation of their
mineralization.

Figure 38: Chemical hydrolysis of PLA and PET polymers.

Figure 39 shows IR spectra of the 3D printed PET and PLA scaffolds after
alkaline treatment for 1 and 6 hours in a highly basic medium. All spectra showed a
high extent of basic hydrolysis of the ester groups of both polymers. This was reflected
in the presence of a high intensity broad band at 3000-3600 cm-1, which is attributed
to the stretching mode of absorption of OH group of both free carboxyl and hydroxyl
functional groups. A minor difference was observed between alkaline treatment for 1
hour versus 6 hours in the spectra of both polymers.
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Figure 39: IR spectra of alkaline-treated (1 and 6 hours) PET and PLA 3D scaffolds.

The extent of surface hydrolysis was also observed in the optical photographs
and SEM micrographs of the treated scaffolds as shown in Figures 40-41. It is evident
that both scaffolds were largely affected by the alkaline treatment when extended for
6 hours, where formation of surface fragments were observed within the open pores of
both porous scaffolds. The SEM micrographs shown in Figure 40, on the other hand,
show an increased surface roughness of PLA scaffold as compared with PET scaffold.
The arrows drawn on the SEM micrographs in Figure 40b clearly indicated the
presence of surface grooves and detailed surface irregularities. It is therefore
concluded that alkaline treatment not only resulted in the formation of potentially
bioactive functional groups (–OH and –COOH), as shown in Figure 39, but also
resulted in an increased surface roughness. Both attributes are recommended for
materials to be used as partial and/or total substitutions of hard tissues, because they
result in an enhanced bonding with the surrounding hard tissues.
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(a)

(b)

Figure 40: Optical photographs at different views of 6 hrs. alkaline-treated 3D printed
scaffolds of PLA and PET.
(a) PET and (b) PLA.

(a)

(b)

Figure 41: SEM micrographs at different magnifications of 6 hrs. alkaline-treated 3D
printed scaffolds.
(a) PET and (b) PLA.
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4.4 Impregnation of 3D Printed Scaffolds
The high porosity of the 3D printed scaffolds that are made of bioactive (PET)
and biodegradable (PLA) polymers strongly recommend them to be used for the
substitution of the highly porous cancellous bone. Accordingly, the currently 3D
fabricated PET and PLA scaffolds were intentionally made highly porous with an
interconnected porosity to resemble natural porous hard tissues. However,
biocompatibility of these scaffolds could be further enhanced by the introduction of
bone-like calcium phosphate pastes. In this regard, slurries made of bone-like
hydroxyapatite (HAp) nanoparticles were used for the impregnation of the as-printed
PET and PLA scaffolds as well as the 1hr and 6hr alkaline-treated scaffolds. Figure 42
shows optical photographs of these scaffolds. The highly stable HAp slurries were
successfully introduced within the open and connected porosities of the scaffolds.
Moreover, the detailed optical photographs shown in Figure 43 show that the surface
groves of the scaffolds were also filled by the HAp slurry, as indicated by arrows in
Figure 43b.

(a)

(b)

(c)

(d)

(e)

(f)

(A)

(B)
(C)

Figure 42: Optical photographs of impregnated 3D printed scaffolds.
(A) PET, (B) PLA, and (C) a typical impregnated scaffold. Detailed impregnated scaffolds include
(a&d) as printed, (b&e) alkaline-treated for 1 hr, and (c&f) alkaline-treated for 6 hrs.
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(a)

(b)

Figure 43: Optical photographs of impregnated as-printed 3D scaffolds showing the
full impregnation of the surface and side porosities.
(a) PET, (b) PLA.

Figure 44 shows SEM micrographs of representative porous scaffolds where
pores are completely filled with the HAp slurry. Moreover, the high magnification of
both impregnated scaffolds shown in Figure 44 show the compact nature of the HAp
filling. The presence of HAp filling within the porous scaffolds were further confirmed
by IR analysis of impregnated scaffolds.

(a)

(b)

Figure 44: SEM micrographs at different magnifications of impregnated 3D printed
scaffolds.
(a) PET and (b) PLA.
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Figure 45 shows representative as-printed scaffolds after being impregnated
with HAp slurry. The presence of HAp within the open and surface porosities of the
scaffolds was confirmed by the presence of high intensity bands characteristic to the
main functional group (PO43-) of HAp at 980-1080 cm-1 and the doublet at 560 and
600 cm-1 as shown in Figure 45. The complete filling of the porosities of both scaffolds
explain the domination of the IR spectra of both scaffolds with the main characteristic
bands of HAp.

Figure 45: IR spectra of impregnated alkaline-treated PET and PLA 3D scaffolds.

4.5 SBF treatment of 3D Printed Scaffolds
Treatment of potential biomaterials in simulated body fluids (SBF) is usually
considered a preliminary evaluation of the bioactivity of these materials. As mentioned
in the experimental section, SBF media are protein-free and are composed of ions with
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concentrations similar to those present in the human physiologic media. Therefore, the
preliminary bioactivity of potential biomaterials is assessed by the successful
interaction between the material and the ions in the SBF media; in particular, Ca2+ and
PO43- ions. This process is named “biomimetic” and it resembles the natural
biomineralization of collagen, where Ca2+ and PO43- ions in particular get attracted to
certain functional groups, such as –COOH, -OH, -NH2, and –SO3H groups, and form
the first bone-like nuclei. Growth of these nuclei gives rise to the HAp nanocrystallites
that are present in the hard tissues. Similarly, the presence of any of these groups on
the surfaces of potential biomedical materials gives these materials an affinity towards
the attraction of Ca2+ and PO43- ions from the SBF media and the subsequent nucleation
and growth of bone-like apatite crystallites. An additional reason for the attraction of
these ions to the functional groups shown above is that SBF media are supersaturated
with respect to HAp. Therefore, a spontaneous gravitation of the ions, followed by
HAp nucleation and growth takes place when any or all these functional groups exist
on the surfaces of the tested materials.
In the current study, PLA and PET are initially considered polyesters, which
possess ester groups as well as terminal –OH and –COOH groups. Gravitation and
attraction of Ca2+ ions to these groups is, therefore, expected. Moreover, enhancing the
surface functionality by alkaline treatment is highly expected to enhance the
preliminary bioactivity of the surface-treated scaffolds. Figure 46 shows a chemical
schematic of how alkaline treated PLA sample attracted Ca2+ ions from SBF media
because it is functionalized with -OH groups.
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Figure 46: A schematic showing the effect of alkaline treatment on the surface
functionality of the 3D printed scaffolds towards SBF media.

Figure 47 shows the preliminary evaluation of PLA and PET scaffolds that
have been previously alkaline-treated for 1 hour in 5M NaOH media. Both scaffolds
showed a sudden decrease in the concentrations of Ca2+ and PO43- ions within the first
day after exposure to SBF media. The decrease in the ions indicates their leaching out
of the SBF media as a result of their deposition in the form of bone-like apatite
crystallites onto the alkaline-treated PLA and PET porous scaffolds. The extent of
decrease of Ca2+ ions is more pronounced than that of the PO43- ions, which could be
attributed to the fact that the deposited apatite crystallites have Ca/P molar ratio within
the range of 1.5-1.67. A plateau was reached at the beginning of the second day of
immersion of both alkaline-treated scaffolds in SBF media. This is attributed to the
exhaustion of the Ca2+ and PO43- ions from the medium and their subsequent
transformation to bone-like apatite crystallites.
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Figure 47: Variation of the concentrations of Ca2+ and PO43- ions in SBF as a result of
immersion of 1hr alkaline-treated PET and PLA 3D scaffolds for 14 days.

Based on these results, all PLA and PET 3D porous scaffolds with various
degrees of surface roughness and functionality, by virtue of their alkaline treatment at
different conditions, were evaluated for their performance in SBF media for 21 days.
Figure 48 shows a comparison between the variation of Ca2+ ionic concentration in
SBF media as a result of immersion of rough and smooth PLA 3D porous scaffolds
that are also alkaline-treated for 1 and 6 hours as compared with their corresponding
smooth counterparts. Both sets of samples showed a sudden decrease in the
concentration of Ca2+ ions within the first day of immersion. This was followed by a
plateau for the remaining period of soaking for 21 days. However, the results shown
in Figure 48b for the smooth PLA scaffolds indicate a lower plateau of the Ca2+ ions
concentrations than those in Figure 48a for the rough PLA scaffolds. Theoretically,
rough surfaces are assumed to provide more surfaces for the nucleation and growth of
apatite crystallites. However, these unexpected results could be attributed to the effect
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of exposure to acetone vapor on the creation of more surfaces along the surfaces of the
porous scaffolds. Moreover, smoothening of the samples followed by alkaline
treatment is believed to result in the formation of more functional groups along the
created surfaces, thus allowing for more sites for the attraction, nucleation and growth
of the apatite crystallites. A similar pattern was also observed in Figure 49, where
smooth PET 3D porous samples showed a higher extent of chemical interaction with
the Ca2+ and PO43- ions from the surrounding media. The overall performance of PLA
and PET porous scaffolds towards Ca2+ and PO43- ions in SBF was the same. This
could be attributed to the similarity in the chemical structure of PLA and PET as
polyesters.

Figure 48: Variation of the concentrations of Ca2+ ions in SBF as a result of immersion
of PLA 3D scaffolds for 21 days.
(a) Rough, and (b) smooth PLA 3D scaffolds.
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Figure 49: Variation of the concentrations of Ca2+ ions in SBF as a result of immersion
of PET 3D scaffolds.
(a) Rough, and (b) smooth PET 3D scaffolds for 21 days.

Figure 50: Variation of the concentrations of Ca2+ ions in SBF as a result of immersion
of alkaline-treated 3D scaffolds.
(a) 1 hr. and (b) 6 hrs. alkaline-treated rough and smooth PLA and PET 3D scaffolds for 21 days.

Figure 50 compares the effect of alkaline treatment on the performance of
rough and smooth surfaces of PET and PLA to SBF media for 21 days. A similar
pattern was observed, where extensive alkaline treatment for 6 hours was not shown
to increase the affinity of the alkaline-treated scaffolds towards the surrounding Ca2+
and PO43- ions in SBF media. This could be attributed to the leach out of the major
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portions of these ions from the medium and their subsequent precipitation onto the
surfaces of the scaffolds. Moreover, alkaline treatment takes place on the exposed
surfaces of the scaffolds, which are presumed to have the same surface area, hence a
similar behavior in SBF was shown.
Performance of PLA and PET 3D scaffolds in SBF media was further studied
by SEM to evaluate the morphological changes of their surfaces as a function of the
type of treatment. Figure 51 shows SEM micrographs of rough and smooth PLA 3D
scaffolds with various extents of surface treatments, compared with that of the pristine
3D PLA scaffold. Low magnification SEM micrographs indicate the difference in
surface roughness between the initially as-printed rough scaffolds and those
smoothened via exposure to acetone vapor. In contrast, a low magnification SEM
micrograph of the as printed scaffold shows its high degree of surface roughness. A
similar pattern could be observed in Figure 52 for the PET scaffolds. However, the
initial relative surface smoothening of the PET scaffolds, compared with the PLA
scaffolds, was observed. Figure 26 shows SEM micrographs at a higher magnification
of the PLA scaffolds. All scaffolds showed evidence of deposition of apatite granules.
However, the extent of deposition of these granules was higher in the smooth surfaces
that are alkaline-treated. Figure 53f shows the highest extent of apatite deposition,
where a combination of surface smoothening and alkaline treatment for 6 hours is
shown to provide the highest degree of preliminary bioactivity. Moreover, the apatite
coating observed in Figure 26c and f for the alkaline-treated rough and soft PLA
scaffolds indicate the extensive coverage of all irregular shaped surfaces including the
surface porosities. Figure 54 shows a similar pattern for all PET porous scaffolds,
especially those chemically treated in alkaline media for 1 and 6 hours. Moreover, the
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extent of apatite coverage was more pronounced in the smoothened PET scaffolds that
were alkaline treated for 6 hours.

Figure 51: SEM micrographs at low magnification of PLA 3D scaffolds.
(A) As-printed, (B) rough SBF-treated: (b) as-printed, (c) 1hr alkaline-treated, (d) 6 hrs. alkalinetreated, and (C) smooth SBF-treated SBF-treated: (e) as-printed, (f) 1hr alkaline-treated, (g) 6 hrs.
alkaline-treated.
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Figure 52: SEM micrographs at low magnification of PET 3D scaffolds.
(A) As-printed, (B) rough SBF-treated: (b) as-printed, (c) 1hr alkaline-treated, (d) 6 hrs. alkaline-treated,
and (C) smooth SBF-treated SBF-treated: (e) as-printed, (f) 1hr alkaline-treated, (g) 6 hrs. alkalinetreated.

Figure 53: SEM micrographs at high magnification of PLA 3D scaffolds.
(A) Rough SBF-treated: (a) as-printed, (b) 1hr alkaline-treated, (c) 6 hrs. alkaline-treated, and (B)
smooth SBF-treated SBF-treated: (d) as-printed, (e) 1hr alkaline-treated, (f) 6 hrs. alkaline-treated.
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Figure 54: SEM micrographs at high magnification of PET 3D scaffolds.
(A) Rough SBF-treated: (a) as-printed, (b) 1hr alkaline-treated, (c) 6 hrs. alkaline-treated, and (B)
smooth SBF-treated SBF-treated: (d) as-printed, (e) 1hr alkaline-treated, (f) 6 hrs. alkaline-treated.

The deposition of apatite onto 3D porous scaffolds that have been presubjected to various types of treatments were also investigated by elemental analysis
of the deposited granules. Figures 55 and 56 show EDX elemental analysis of the
apatite coverage of the rough, and smooth PLA porous scaffolds, respectively, that
have been alkaline treated for 6 hours. Both coatings showed the presence of Ca and
P elements in their coatings. However, the relative intensities of the Ca and P peaks in
the EDX pattern of the soft PLA porous scaffold were higher than those of the rough
PLA porous scaffold. Similarly, an extensive presence of apatite granules onto the
surface of 6 hrs. alkaline-treated soft PET porous scaffold was evident in Figure 58b.
In comparison with EDX pattern of apatite grown onto the corresponding rough
counterpart. (Figure 57) confirms the above observed findings. An extensive
confirmation of the formation of full coverage of apatite onto the surface of a soft PET
porous scaffold that was also alkaline treated for 6 hours was studied by EDX mapping
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of its elements, as shown in Figure 59. The homogeneous existence and distribution of
Ca and P elements is an additional evidence of apatite mineralization onto these
surfaces, hence their potential application as a partial or total substitution of hard
tissues.

Figure 55: SEM micrograph and EDX spectrum of rough 6 hrs. alkaline-treated PLA
scaffold after SBF treatment for 21 days.
SEM micrograph (a) and EDX spectrum (b).

Figure 56: SEM micrograph and EDX spectrum of smooth 6 hrs. alkaline-treated PLA
scaffold after SBF treatment for 21 days.
SEM micrograph (a) and EDX spectrum (b).
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Figure 57: SEM micrograph and EDX spectrum of rough 6 hrs. alkaline-treated PET
scaffold after SBF treatment for 21 days.
SEM micrograph (a) and EDX spectrum (b).

Figure 58: SEM micrograph and EDX spectrum of smooth 6 hrs. alkaline-treated PET
scaffold after SBF treatment for 21 days.
SEM micrograph (a) and EDX spectrum (b).

Figure 59: SEM micrograph and EDX elemental mapping of smooth 6 hrs. alkalinetreated PET scaffold after SBF treatment for 21 days.
SEM micrograph (a) and EDX elemental mapping (b).
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It should be mentioned that the deposition of apatite onto the surface of
functionalized scaffolds results in the formation of a thin layer. Therefore, the
characterization of the apatite coverage was attempted by IR spectroscopy, as shown
in Figures 60-61. Both rough and smooth PET scaffolds treated with SBF showed
similar IR spectra to that of the untreated pristine samples, as shown in Figure 60a and
b. All bands were matching and no variation in their intensities was shown and no new
bands were observed. A similar pattern was observed in Figure 61a and b, where rough
and smooth PLA scaffolds showed similar IR spectra to that of pristine PLA scaffold.
However, a slight variation was observed in the IR spectra of both rough and smooth
PLA scaffolds that were alkaline treated for 6 hours before SBF treatment. A higher
extent of hydrolysis as a result of alkaline treatment could be observed in the spectra
of these samples. This is shown in the increased intensity of the broad bands around
3400 cm-1, which is attributed to –OH stretching mode of vibration. Based on these
findings, it is evident that the thin nature of the apatite coating developed onto the
surfaces of the highly alkaline-treated PLA and PET scaffolds was not reflected in
changes in their IR spectra. Moreover, it should be mentioned that XRD technique,
which is normally used as an evidence to show the existence of inorganic crystalline
materials, such as HAp, was not used in the current study due to the nature of the thinlayer of apatite. This does not negate the presence of apatite coating onto the 3D
scaffolds of both PET and PLA, due to the fact that a strong evidence of apatite
formation was observed by SEM and EDX techniques.

87

Figure 60: IR spectra of SBF-treated PET 3D scaffolds after 21 days.
(a) rough, and (b) smooth PET 3D scaffolds

Figure 61: IR spectra of SBF-treated PLA 3D scaffolds after 21 days.
(a) rough, and (b) smooth PLA 3D scaffolds

A representation of the mechanism of growth of bone-like apatite onto the
surface of potential biomaterial implant in SBF media is shown in schematic of Figure
62. The presence of functional groups that have affinity towards the deposition of
apatite granules is a pre-requisite for this process to take place. SBF media are protein-
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free and contain ions with concentrations that are similar to those in the physiologic
media, such as blood plasma. Moreover, SBF media are normally super-saturated with
respect to apatite phase. This is the second main concept that facilitates the deposition
of apatite onto the material’s surface functional groups mentioned above. The process
starts with the gravitation of Ca2+ ions from the surrounding media onto the surface of
the material, followed by gravitation and attraction of the PO43- ions onto the preadsorbed Ca2+ ions. With the pre-adjusted molar concentrations of Ca2+ and PO43- ions
in SBF media, their agglomeration onto the surface of the material results in the
formation of apatite with a Ca/P ratio within the biologically acceptable range; 1.51.67. The continuous gravitation and attraction of Ca2+ and PO43- ions results in the
nucleation and growth of apatite granules onto the surface of the material. The
homogeneous distribution of surface functionalities in a porous scaffold results in the
simultaneous mineralization of these surfaces with apatite onto and into the surfaces
and pores of the scaffold.
The importance of SBF treatment stems from the facts that it is considered an
initial evaluation of the in vitro affinity of a potential biomaterial implant. Therefore,
a material that supports the formation and growth of apatite indicates its potential to
interact with these ions after implantation and show a high potential for biomineralization after implantation. Hence, this is considered a preliminary in vitro
evaluation of the material. Moreover, SBF treatment provides an additional approach
for the pre-conditioning of potential biomaterial scaffolds before being used as
implants where the growth of a bone-like apatite layer provides a bioactive interface
that is highly expected to facilitate bonding of the biomaterial after implantation.
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Figure 62: A schematic diagram showing the mechanism of deposition of bone-like
apatite spherulites onto/into 3D porous scaffolds with time during a process of 21 days
of treatment in SBF media.

4.6 Growth of MOF onto/into 3D Printed Scaffolds
ABS was selected as a bioinert material with a potential for the development
of porous scaffolds as total or partial substitution of cancellous bone. However, the
chemical structure of ABS indicates the absence of surface functionalities that are
expected to show an affinity towards biomineralization in SBF media in a similar
manner to PLA and PET. Instead, ABS was investigated in the current study as a
platform for the growth of metal-organic framework (MOF) hierarchical porous
structures that can be used for the encapsulation and delivery of bone morphogenic
proteins, growth hormones and drugs. A model MOF was selected in the current study,
which is HKUST-1. This is a Cu-based MOF that has been shown to have an
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antibacterial, antifungal and anticancer potential (Bouson et al., 2017; Cerón et al.,
2016; Lis et al., 2019).
The process of formation and growth of HKUST-1 onto ABS takes place
through a layer-by-layer approach, as depicted in Figure 63. Initially, 3D-printed ABS
porous scaffolds were pre-conditioned in the same solvent mixture that is used for the
preparation of HKUST-1 in a typical procedure. Through a layer-by-layer approach,
solutions containing Cu2+ ions clusters and TMA organic linker were used for the
successive formation and growth of HKUST-1. In this regard, Cu2+ ions are attracted
and bonded to the pre-conditioned ABS scaffolds through stage 1 of the first cycle of
HJUST-1 formation. This is followed by stage 2 of the first cycle, where treatment of
the Cu2+-containing ABS scaffold with a solution of the TMA results in the formation
of the first layer of HKUST-1 structure through the bonding between the Cu2+ ions and
the carboxyl functional groups of the TMA. Both stages formulate the first cycle of
treatment. Repeating this cycle in the same sequence results in the growth of HKUST1 MOF onto the ABS scaffold surfaces. A subsequent color change of the scaffolds
throughout these cycles was observed, as shown in Figure 63. A characteristic
coloration of the HKUST-1 is shown to increase in intensity with increasing the cycle
number as a result of the continuous growth of HKUST-1 onto/into ABS porous
scaffold.
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Figure 63: Optical photographs of ABS 3D porous scaffolds showing the development
of color as a result of the layer-by-layer deposition of HKUST-1 after 4 cycles.

Development of the morphology of HKUST-1 grown onto ABS with time is
shown at low and high magnifications in Figures 64 and 65, respectively. An evident
sign of deposition of the MOF structure onto the porous ABS scaffold is shown in
Figure 63. The surface features shown in the SEM micrograph of the pristine ABS
(Figure 64a) started to disappear with increasing the cycle number as a result of being
covered with the newly deposited MOF layers. Higher magnification SEM
micrographs in Figure 65 clearly indicate the morphology of the deposited HKUST-1
nanogranules. Figure 65b shows that the deposition of the HKUST-1 granules took
place copying the features of the underlying groves of the ABS surface. With
increasing the exposure to the Cu2+ ions and TMA solutions, the extent of coverage
increased (Figure 65c  65e). Moreover, fibrous morphology of HKUST-1 was also
shown at higher cycles of exposure. Those are referred to by arrows in the SEM
micrographs in Figures 65d and 65e.
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Figure 64: SEM low magnification micrographs of HKUST-1 grown onto ABS 3D
porous scaffold after 4 complete cycles of layer-by-layer deposition technique.

Figure 65: SEM high magnification micrographs of HKUST-1 grown onto ABS 3D
porous scaffold after 4 complete cycles.
Cycles of layer-by-layer deposition technique (arrows refer to fibrous morphology of HKUST-1).
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Figure 66: SEM high magnification micrographs of HKUST-1 grown onto ABS 3D
porous scaffold during the last 2 complete cycles.
Cycles of layer-by-layer deposition technique showing the development of HKUST-1 crystals
formation (arrows refer to fibrous morphology of HKUST-1)

A higher magnification was further carried out for the last 2 complete cycles,
as shown in Figure 66. A mixture of fibrous and nanocrystalline HKUST-1 was found
in the micrographs of these samples. Fibrous HKUST-1 was previously shown to be
produced by varying the proportion of water in the solvent system used during the
deposition of HKUST-1 (Van Assche et al., 2012). In these experiments, the
proportion of water was varied between 50% and 65%. Fibrous HKUST-1 was
observed in the micrographs of the samples made from solutions containing a higher
proportion of water (65%), which is therefore in accordance with what was observed
in the literature (Van Assche et al., 2012). Moreover, a higher extent of crystallization
was found after the last cycle, indicating the possibility of improving the crystallinity
of the deposited HKUST-1 with increasing the cycles of exposure to the HKUST-1
precursors.
In order to evaluate the variation in the morphology of the deposited HKUST1 as a function of solvent, 3D printed ABS porous thin sheets were also fabricated. A
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solvent system that contains 65% water and 35% ethanol was used. Figure 67 shows
the color development of the HKUST-1-coated ABS sheets with increasing the cycle
number for a total of 4 complete cycles (8 individual exposure experiments). These
optical photographs also indicate the formation of HKUST-1 in the surrounding
medium, which reflects the interaction between the Cu2+ ions and the TMA reactants
and the spontaneous formation of HKUST-1 precipitates. Figure 68 shows the SEM
micrographs of the ABS sheets at different magnifications after the completion of 4
complete cycles of immersion in the Cu2+ ions and TMA solutions. A layer
morphology was observed in the morphology of the deposited HKUST-1 layer. An
interlocking between the HKUST-1 sheet-like morphology was also observed.
However, signs of HKUST-1 with different morphologies were also observed in the
SEM micrographs of these samples, as observed in Figure 68b. A confirmation of the
elemental composition of the deposited HKUST-1 granules is shown in the EDX
analysis of the ABS sheets coated with HKUST-1 at different spots in Figure 69.

Figure 67: Optical photographs showing color development as a result of the growth
of HKUST-1 onto ABS 3D porous scaffold.
After 4 complete cycles during layer-by-layer deposition technique (every successive photographs
represent a complete cycle).
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Figure 68: SEM micrographs of HKUST-1 grown onto ABS 3D porous.
SEM micrographs at different magnifications after the completion of 4 complete cycles of later-bylayer deposition technique.

(a)

(b)

Figure 69: SEM micrograph and EDX spectrum at different locations for HKUST-1
grown onto ABS 3D porous scaffold.
(a) SEM micrograph and EDX of points (1) in (a) and (2) in (b) of HKUST-1 grown onto ABS 3D
porous scaffold after 4 complete cycles using a layer-by-layer deposition technique.
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An investigation of the phase composition of the deposited HKUST-1 film was
carried out using XRD and IR techniques. Figure 70 shows XRD patterns of HKUST1 film versus that of the same phase in a bulk format. It should be mentioned that
crystal structure and morphology of a MOF dictates the variation in the intensities of
the peaks representing the MOF structure. This was shown in Figure 70, where a bulk
crystalline powder showed a slightly different pattern than a 2D film in the form of
mixed morphologies of fibers and flakes. The formation of HKUST-1 in the form of
films or with fibrous morphologies was previously confirmed to affect the XRD
pattern of the produced phase due to the effect of crystalline arrangement of the phase
on the produced morphology (Zhuang et al., 2011). A 2D and film morphology of
HKUST-1 contains 2D crystal lattice of the phase, as shown in Figure 71a.
The deposition of HKUST-1 onto the 3D ABS scaffold was also investigated
by IR spectroscopy, as shown in Figure 72. Compared with the un-coated ABS
scaffold, the presence of HKUST-1 onto the surfaces of ABS resulted in a decrease in
the intensities of the major bands characteristic to ABS, while bands characteristic to
the organic linker; TMA, were observed. A band at 1650 cm-1 is characteristic to the
stretching mode of the C=O functional group of the TMA. In addition, the noisy areas
above 3500 cm-1 and 400-650 cm-1 are believed to contain unreacted OH groups as
well as Cu-O bonds, respectively.
Based on the above findings, it is evident that HKUST-1 with various
morphologies could be formed onto the surfaces and into the pores of ABS porous
scaffolds. The MOF-functionalized bioinert ABS scaffolds are highly believed to be
used for the partial and total replacement of cancellous bone where the organic
functionality of the MOF coating and the outstanding interconnected porosity of the
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hierarchical structure of HKUST-1 could be used for the encapsulation of drugs and
biomolecules to supplement the functions of the ABS hard tissues substitutions.

Figure 70: XRD pattern of HKUST-1 film grown onto ABS 3D porous scaffold.
After 4 complete cycles using a layer-by-layer deposition technique as compared with that of
HKUST-1 powder grown in bulk (no scaffold).

Figure 71: Representation of the crystal structure of a typical HKUST-1.
In the bulk form (a) and in the 2D film geometry (b). A yellow sphere represents an open cavity
(porosity) inside the crystal structure of HKUST-1.
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Figure 72: IR spectra of HKUST-1 grown onto ABS 3D porous scaffold.
IR Spectra after 4 cycles of layer-by-layer deposition technique, as compared with that of pristine
ABS scaffold.
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Chapter 5: Conclusion and Future Perspectives

The current study investigated the fabrication and characterization of 3D
porous scaffolds using a 3D printing technology. Moreover, the surfaces of the
fabricated scaffolds were chemically modified to enhance their potential for
biomedical applications, particularly as implants for defective cancellous bone.
5.1 Conclusions
Three type of polymers were 3D printed; PLA, PET and ABS. These polymers
are classified as biodegradable, bioactive and bioinert, respectively. Moreover, surface
functionalization has been carried out to enhance their potential for biomedical
applications. A CAD design, made by solidworks software, was used for the 3D
printing of the porous scaffolds using an ULTIMAKER 2+ 3D printer. PLA and PET
porous scaffolds were further smoothened using a solvent exposure approach, where
these as-printed scaffolds were exposed to acetone vapor. Moreover, PLA and PET,
both as-printed and smoothened, were subjected to alkaline treatment to partially
hydrolyze their surfaces. Scaffolds were immersed in a highly alkaline (5M NaOH)
medium for 1, 6 and 12 hours. As-printed and smoothened PLA and PET scaffolds
that were also chemically treated and were further impregnated by a bone-like
hydroxyapatite (HAp) slurry. Moreover, as-printed and smoothened PLA and PET
scaffolds that were also chemically treated were evaluated for their potential to grow
bone-like HAp by immersion in a simulated body fluid (SBF) for up to 21 days. On
the other hand, as-printed ABS porous scaffolds were surface conditioned in a mixed
solvent (1:1 H2O:ethanol) before being subjected to the layer-by-layer deposition of a
biodegradable Cu-based metal organic framework (HKUST-1).
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Optical and scanning electron microscopies revealed the high porosity of the
3D printed scaffolds as well as the interconnectivity of their porosities. Smoothening
of the PLA and PET scaffolds showed the minimization of the surface roughness of
the scaffolds, while maintaining the structural integrity of both scaffolds. On the other
hand, alkaline treatment of the as-printed and smoothened PLA and PET scaffolds
showed the possibility of enhanced surface hydrolysis of both scaffolds. This was
confirmed by FTIR analysis of the alkaline-treated scaffolds where bands related to
the –OH and –COOH groups were observed. This is attributed to the alkaline
hydrolysis of the surface ester groups of both PLA and PET scaffolds. A complete
impregnation of the porous scaffolds was achieved, where the produced filled scaffolds
are highly believed to provide an extra support for the potential implant upon
application.
Moreover, smooth and rough PLA and PET that have been alkaline-treated
were evaluated for their preliminary in vitro characteristics by immersing them in a
protein-free simulated body fluid (SBF and 1.5 SBF) for up to 21 days. Results showed
the potential of all scaffolds to grow bone-like HAp onto their surfaces, especially
those scaffolds that were chemically treated. This is attributed to the potential of the
created functional groups (-OH and –COOH) onto the surfaces of both PLA and PET
upon alkaline treatment. These groups are known as nucleating sites for the
biomineralization in nature, hence provides a preliminary evidence for in vitro
bioactivity when used a bone implants.
Surface conditioned ABS porous scaffolds, on the other hand were subjected
to a layer-by-layer deposition of HKUST-1. XRD, FTIR and SEM techniques showed
the formation of HKUST-1 nano-agglomerates onto the surfaces of ABS porous
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scaffolds. Moreover, the morphology of the formed HKUST-1 was found to vary with
the composition of the solvent mixture. It is anticipated that the fibrous nature of the
deposited HKUST-1 are composed of 2D Cu-based clusters. The high porosity of the
HKUST-1 coating onto the 3D printed bioinert ABS are, therefore believed to provide
an interactive platform for an enhanced bioactivity upon implantation.
5.2 Future Perspectives
This study showed the potential of fabrication of highly porous scaffolds that
can be used as partial or total replacement of defective cancellous bone, especially
after chemical functionalization. This work provides a start point for further
investigation of the following characteristics in order to evaluate the potential of the
fabricated and chemically-functionalized scaffolds for biomedical applications:
1. Assess the mechanical properties of the as-printed porous scaffolds and as
a function of chemical functionalization.
2. Evaluate the bioactivity of the as-printed and chemically functionalized
porous scaffold in actual cell culture media.
3. Study the possibility of using the layer-by-layer grown HKUST-1 onto
ABS porous scaffolds for the encapsulation of bone biomolecules and
drugs that will further enhance new bone formation upon implantation.
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